Hospital Supply Status (HSS) and Principal Supply Status (PSS) - Cumulative to May 2024
The expiry date of the supply period is 30 June of the year indicated unless otherwise stated. Please note that the supply may have been awarded for a wider scope than just those presentation(s) listed below.
| Status | Chemical | Presentation | Brand | Pharmacode | SSS/PSS Period |
|---|---|---|---|---|---|
| PSS | Abacavir sulphate with lamivudine | Tab 600 mg with lamivudine 300 mg | Abacavir/lamivudine Viatris | 2632365 | May 2023 to 2025 |
| PSS | Acarbose | Tab 100 mg | Accarb | 2402416 | Dec 2021 to 2024 |
| PSS | Acarbose | Tab 50 mg | Accarb | 2402408 | Dec 2021 to 2024 |
| PSS | Aciclovir | Eye oint 3% | ViruPOS | 2490803 | Sep 2021 to 2024 |
| PSS | Aciclovir | Inj 250 mg vial | Aciclovir-Baxter | 2599414 | Jan 2022 to 2024 |
| PSS | Aciclovir | Tab dispersible 200 mg | Lovir | 471704 | Mar 2023 to 2025 |
| PSS | Aciclovir | Tab dispersible 400 mg | Lovir | 471690 | Apr 2023 to 2025 |
| PSS | Aciclovir | Tab dispersible 800 mg | Lovir | 471712 | Apr 2023 to 2025 |
| PSS | Acitretin | Cap 10 mg | Novatretin | 2384167 | Jul 2024 to 2026 |
| PSS | Acitretin | Cap 25 mg | Novatretin | 2384175 | Jul 2024 to 2026 |
| PSS | Adalimumab (Amgevita) | Inj 20 mg per 0.4 ml prefilled syringe | Amgevita | 2631121 | Oct 2022 to 31~Jul~2026 |
| PSS | Adalimumab (Amgevita) | Inj 40 mg per 0.8 ml prefilled pen | Amgevita | 2631105 | Oct 2022 to 31~Jul~2026 |
| PSS | Adalimumab (Amgevita) | Inj 40 mg per 0.8 ml prefilled syringe | Amgevita | 2631113 | Oct 2022 to 31~Jul~2026 |
| PSS | Adrenaline | Inj 0.15 mg per 0.3 ml auto-injector | Epipen Jr | 208191 | Jul 2023 to 2025 |
| PSS | Adrenaline | Inj 0.3 mg per 0.3 ml auto-injector | Epipen | 223972 | Jul 2023 to 2025 |
| PSS | Alendronate sodium | Tab 70 mg | Fosamax | 2022133 | Jul 2024 to 2026 |
| PSS | Alendronate sodium with colecalciferol | Tab 70 mg with colecalciferol 5,600 iu | Fosamax Plus | 2337053 | Jul 2024 to 2026 |
| PSS | Alfentanil | Inj 0.5 mg per ml, 2 ml ampoule | Medsurge | 2650991 | Feb 2024 to 2026 |
| PSS | Allopurinol | Tab 100 mg | Ipca-Allopurinol | 2666855 | Jun 2024 to 2026 |
| PSS | Allopurinol | Tab 300 mg | Ipca-Allopurinol | 2666863 | Jun 2024 to 2026 |
| PSS | Ambrisentan | Tab 10 mg | Ambrisentan Viatris | 2626454 | Dec 2023 to 2026 |
| PSS | Ambrisentan | Tab 5 mg | Ambrisentan Viatris | 2626446 | Dec 2023 to 2026 |
| PSS | Amikacin | Inj 250 mg per ml, 2 ml vial | DBL Amikacin | 2572214 | Dec 2021 to 2024 |
| PSS | Amiodarone hydrochloride | Inj 50 mg per ml, 3 ml ampoule | Max Health | 2565129 | Dec 2022 to 2025 |
| PSS | Amiodarone hydrochloride | Tab 100 mg | Aratac | 770620 | Dec 2022 to 2025 |
| PSS | Amiodarone hydrochloride | Tab 200 mg | Aratac | 770639 | Dec 2022 to 2025 |
| PSS | Amitriptyline | Tab 10 mg | Arrow-Amitriptyline | 2404451 | Mar 2024 to 2026 |
| PSS | Amitriptyline | Tab 25 mg | Arrow-Amitriptyline | 2461250 | Mar 2024 to 2026 |
| PSS | Amitriptyline | Tab 50 mg | Arrow-Amitriptyline | 2461269 | Mar 2024 to 2026 |
| PSS | Amlodipine | Tab 10 mg | Vasorex | 2592525 | Feb 2024 to 2026 |
| PSS | Amlodipine | Tab 2.5 mg | Vasorex | 2592509 | Feb 2024 to 2026 |
| PSS | Amlodipine | Tab 5 mg | Vasorex | 2592517 | Feb 2024 to 2026 |
| PSS | Amorolfine | Nail soln 5% | MycoNail | 2461633 | Feb 2024 to 2026 |
| PSS | Amoxicillin | Cap 250 mg | Miro-Amoxicillin | 2669617 | Sep 2024 to 2025 |
| PSS | Amoxicillin | Cap 500 mg | Miro-Amoxicillin | 2669625 | Aug 2024 to 2025 |
| PSS | Amoxicillin | Grans for oral liq 125 mg per 5 ml | Alphamox 125 | 2503557 | Feb 2024 to 2026 |
| PSS | Amoxicillin | Grans for oral liq 250 mg per 5 ml | Alphamox 250 | 2503565 | Feb 2024 to 2026 |
| PSS | Amoxicillin with clavulanic acid | Inj 1,000 mg with clavulanic acid 200 mg vial | Amoxiclav multichem | 2613417 | Dec 2021 to 2024 |
| PSS | Amoxicillin with clavulanic acid | Inj 500 mg with clavulanic acid 100 mg vial | Amoxiclav multichem | 2613425 | Dec 2021 to 2024 |
| PSS | Amoxicillin with clavulanic acid | Tab 500 mg with clavulanic acid 125 mg | Curam Duo 500/125 | 2602121 | Feb 2024 to 2026 |
| PSS | Anastrozole | Tab 1 mg | Anatrole | 2520079 | Dec 2023 to 2026 |
| PSS | Aprepitant | Cap 2 x 80 mg and 1 x 125 mg | Emend Tri-Pack | 2244098 | Dec 2021 to 2024 |
| PSS | Aqueous cream | Crm 500 g | GEM Aqueous Cream | 2615592 | Jul 2022 to 2024 |
| PSS | Aripiprazole | Tab 10 mg | Aripiprazole Sandoz | 2544539 | Oct 2022 to 2025 |
| PSS | Aripiprazole | Tab 15 mg | Aripiprazole Sandoz | 2544547 | Oct 2022 to 2025 |
| PSS | Aripiprazole | Tab 20 mg | Aripiprazole Sandoz | 2544555 | Oct 2022 to 2025 |
| PSS | Aripiprazole | Tab 30 mg | Aripiprazole Sandoz | 2544563 | Oct 2022 to 2025 |
| PSS | Aripiprazole | Tab 5 mg | Aripiprazole Sandoz | 2544520 | Oct 2022 to 2025 |
| PSS | Ascorbic acid | Tab 100 mg | Cvite | 2642255 | Feb 2023 to 2025 |
| PSS | Aspirin | Tab dispersible 300 mg | Ethics Aspirin | 2184338 | May 2024 to 2026 |
| PSS | Aspirin | Tab 100 mg | Ethics Aspirin EC | 2184281 | Jun 2024 to 2026 |
| PSS | Aspirin | Tab 100 mg | Ethics Aspirin EC | 2213621 | Jun 2024 to 2026 |
| HSS | Atazanavir sulphate | Cap 150 mg | Atazanavir Mylan | 2640015 | May 2023 to 2025 |
| PSS | Atazanavir sulphate | Cap 200 mg | Atazanavir Mylan | 2642794 | May 2023 to 31~May~2024 |
| PSS | Atazanavir sulphate | Cap 200 mg | Atazanavir Viatris | 2660024 | May 2023 to 31~May~2024 |
| PSS | Atenolol | Tab 100 mg | Mylan Atenolol | 2279274 | Jan 2022 to 2024 |
| PSS | Atenolol | Tab 50 mg | Viatris | 2627140 | Jun 2023 to 2024 |
| PSS | Atomoxetine | Cap 10 mg | APO-Atomoxetine | 2638517 | Aug 2024 to 2026 |
| PSS | Atomoxetine | Cap 100 mg | APO-Atomoxetine | 2638541 | Aug 2024 to 2026 |
| PSS | Atomoxetine | Cap 18 mg | APO-Atomoxetine | 2637065 | Aug 2024 to 2026 |
| PSS | Atomoxetine | Cap 25 mg | APO-Atomoxetine | 2637073 | Aug 2024 to 2026 |
| PSS | Atomoxetine | Cap 40 mg | APO-Atomoxetine | 2637081 | Aug 2024 to 2026 |
| PSS | Atomoxetine | Cap 60 mg | APO-Atomoxetine | 2638525 | Aug 2024 to 2026 |
| PSS | Atomoxetine | Cap 80 mg | APO-Atomoxetine | 2638533 | Aug 2024 to 2026 |
| PSS | Atorvastatin | Tab 10 mg | Lorstat | 2493586 | Dec 2021 to 2024 |
| PSS | Atorvastatin | Tab 20 mg | Lorstat | 2493594 | Dec 2021 to 2024 |
| PSS | Atorvastatin | Tab 40 mg | Lorstat | 2493608 | Dec 2021 to 2024 |
| PSS | Atorvastatin | Tab 80 mg | Lorstat | 2493616 | Dec 2021 to 2024 |
| PSS | Atropine sulphate | Inj 600 mcg per ml, 1 ml ampoule | Martindale | 2528754 | Jan 2022 to 2024 |
| PSS | Atropine sulphate | Eye drops 1% | Atropt | 200905 | Feb 2024 to 2026 |
| PSS | Azacitidine | Inj 100 mg vial | Azacitidine Dr Reddy's | 2550083 | Dec 2021 to 2024 |
| PSS | Azathioprine | Tab 25 mg | Azamun | 2465345 | Apr 2023 to 2025 |
| PSS | Azathioprine | Tab 50 mg | Azamun | 390003 | Mar 2023 to 2025 |
| HSS | Azithromycin | Tab 500 mg | Zithromax | 204218 | Dec 2021 to 2024 |
| HSS | Bacillus calmette-guerin vaccine | Inj Mycobacterium bovis BCG (Bacillus Calmette-Guerin), Danish strain 1331, live attenuated, vial with diluent | BCG Vaccine | 2461854 | Oct 2020 to 2024 |
| PSS | Baclofen | Inj 2 mg per ml, 5 ml ampoule | Medsurge | 2560054 | Dec 2021 to 2024 |
| PSS | Bendamustine hydrochloride | inj 100 mg vial | Ribomustin | 2483793 | Sep 2021 to 2024 |
| PSS | Bendamustine hydrochloride | Inj 25 mg vial | Ribomustin | 2483807 | Sep 2021 to 2024 |
| PSS | Bendroflumethiazide [Bendrofluazide] | Tab 2.5 mg | Arrow-Bendrofluazide | 2351420 | Mar 2024 to 2026 |
| PSS | Bendroflumethiazide [Bendrofluazide] | Tab 5 mg | Arrow-Bendrofluazide | 2351439 | Mar 2024 to 2026 |
| PSS | Benzylpenicillin sodium [Penicillin G] | Inj 600 mg (1 million units) vial | Sandoz | 433748 | Feb 2024 to 2026 |
| PSS | Betahistine dihydrochloride | Tab 16 mg | Serc | 2611376 | Dec 2023 to 2026 |
| PSS | Betamethasone dipropionate | Crm 0.05% | Diprosone | 210870 | Jul 2024 to 2026 |
| PSS | Betamethasone dipropionate | Oint 0.05% | Diprosone | 210897 | Jul 2024 to 2026 |
| PSS | Betamethasone dipropionate with calcipotriol | Oint 500 mcg with calcipotriol 50 mcg per g | Daivobet | 2170914 | Dec 2021 to 2024 |
| PSS | Betamethasone dipropionate with calcipotriol | Gel 500 mcg with calcipotriol 50 mcg per g | Daivobet | 2553015 | Dec 2021 to 2024 |
| PSS | Betamethasone valerate | Crm 0.1% | Beta Cream | 2188740 | Jan 2022 to 2024 |
| PSS | Betamethasone valerate | Oint 0.1% | Beta Ointment | 2188759 | Jan 2022 to 2024 |
| PSS | Betamethasone valerate | Lotn 0.1% | Betnovate | 210110 | Mar 2022 to 2024 |
| PSS | Betamethasone valerate | Scalp app 0.1% | Beta Scalp | 512877 | Jan 2022 to 2024 |
| PSS | Bezafibrate | Tab 200 mg | Bezalip | 474223 | Feb 2022 to 2024 |
| PSS | Bezafibrate | Tab long-acting 400 mg | Bezalip Retard | 354333 | Feb 2022 to 2024 |
| PSS | Bicalutamide | Tab 50 mg | Binarex | 2523655 | Dec 2023 to 2026 |
| PSS | Bimatoprost | Eye drops 0.03% | Bimatoprost Multichem | 2545128 | Apr 2022 to 2024 |
| PSS | Bisacodyl | Suppos 10 mg | Lax-Suppositories | 2485397 | Dec 2021 to 2024 |
| PSS | Bisacodyl | Tab 5 mg | Bisacodyl Viatris | 2631881 | Jan 2023 to 2025 |
| PSS | Bisoprolol fumarate | Tab 10 mg | Ipca-Bisoprolol | 2660377 | Apr 2024 to 2026 |
| PSS | Bisoprolol fumarate | Tab 2.5 mg | Ipca-Bisoprolol | 2660350 | Apr 2024 to 2026 |
| PSS | Bisoprolol fumarate | Tab 5 mg | Ipca-Bisoprolol | 2660369 | Apr 2024 to 2026 |
| PSS | Bortezomib | Inj 3.5 mg vial | DBL Bortezomib | 2647583 | May 2023 to 2025 |
| PSS | Bosentan | Tab 125 mg | Bosentan Dr Reddy's | 2550075 | Dec 2021 to 2024 |
| PSS | Bosentan | Tab 62.5 mg | Bosentan Dr Reddy's | 2550067 | Dec 2021 to 2024 |
| PSS | Brimonidine tartrate | Eye drops 0.2% | Arrow-Brimonidine | 2396513 | Jan 2022 to 2024 |
| PSS | Brinzolamide | Eye drops 1% | Azopt | 2117061 | Sep 2021 to 2024 |
| PSS | Budesonide | Cap modified-release 3 mg | Budesonide Te Arai | 2661454 | Apr 2024 to 2025 |
| PSS | Bupivacaine hydrochloride | Inj 5 mg per ml, 4 ml ampoule | Marcain Isobaric | 2209284 | Feb 2024 to 2026 |
| PSS | Bupivacaine hydrochloride | Inj 2.5 mg per ml, 20 ml ampoule sterile pack | Marcain | 728071 | Feb 2024 to 2026 |
| PSS | Bupivacaine hydrochloride with fentanyl | Inj 1.25 mg with fentanyl 2 mcg per ml, 100 ml bag | Bupafen | 2594242 | Jan 2023 to 2025 |
| PSS | Bupivacaine hydrochloride with fentanyl | Inj 1.25 mg with fentanyl 2 mcg per ml, 200 ml bag | Bupafen | 2594250 | Jan 2023 to 2025 |
| PSS | Bupivacaine hydrochloride with glucose | Inj 0.5% with glucose 8%, 4 ml ampoule | Marcain Heavy | 2184435 | Sep 2022 to 2025 |
| PSS | Buprenorphine with naloxone | Tab 2 mg with naloxone 0.5 mg | Buprenorphine Naloxone BNM | 2574004 | Dec 2022 to 2025 |
| PSS | Buprenorphine with naloxone | Tab 8 mg with naloxone 2 mg | Buprenorphine Naloxone BNM | 2574012 | Dec 2022 to 2025 |
| PSS | Bupropion hydrochloride | Tab modified-release 150 mg | Zyban | 2439743 | May 2024 to 2026 |
| PSS | Buspirone hydrochloride | Tab 10 mg | Buspirone Viatris | 2615363 | May 2022 to 2024 |
| PSS | Buspirone hydrochloride | Tab 5 mg | Buspirone Viatris | 2615355 | May 2022 to 2024 |
| PSS | Calcitriol | Cap 0.25 mcg | Calcitriol-AFT | 2091038 | Dec 2022 to 2025 |
| PSS | Calcitriol | Cap 0.5 mcg | Calcitriol-AFT | 2091011 | Dec 2022 to 2025 |
| PSS | Calcium carbonate | Tab 1.25 g (500 mg elemental) | Calci-Tab 500 | 2212269 | Feb 2024 to 2026 |
| PSS | Candesartan cilexetil | Tab 16 mg | Candestar | 2380420 | Dec 2021 to 2024 |
| PSS | Candesartan cilexetil | Tab 32 mg | Candestar | 2380439 | Dec 2021 to 2024 |
| PSS | Candesartan cilexetil | Tab 4 mg | Candestar | 2380404 | Dec 2021 to 2024 |
| PSS | Candesartan cilexetil | Tab 8 mg | Candestar | 2380412 | Dec 2021 to 2024 |
| PSS | Capecitabine | Tab 150 mg | Capecitabine Viatris | 2634929 | Jan 2024 to 2025 |
| PSS | Capecitabine | Tab 500 mg | Capecitabine Viatris | 2634937 | Jan 2024 to 2025 |
| PSS | Captopril | Oral liq 5 mg per ml | DP-Captopril | 2657775 | Apr 2024 to 2026 |
| PSS | Carbimazole | Tab 5 mg | Neo-Mercazole | 594423 | Sep 2022 to 2025 |
| PSS | Carmustine | Inj 100 mg vial | BiCNU | 2571234 | Sep 2022 to 2025 |
| PSS | Caspofungin | Inj 50 mg vial | Alchemy Caspofungin | 2647567 | Apr 2023 to 2025 |
| PSS | Caspofungin | Inj 70 mg vial | Alchemy Caspofungin | 2647575 | Apr 2023 to 2025 |
| PSS | Cefaclor | Cap 250 mg | Ranbaxy-Cefaclor | 2149389 | Apr 2023 to 2025 |
| PSS | Cefaclor | Grans for oral liq 25 mg per ml | Ranbaxy-Cefaclor | 471674 | Apr 2023 to 2025 |
| PSS | Cefalexin | Cap 250 mg | Cephalexin ABM | 2498871 | Apr 2023 to 2025 |
| PSS | Cefalexin | Cap 500 mg | Cephalexin ABM | 2361248 | Apr 2023 to 2025 |
| PSS | Cefalexin | Grans for oral liq 25 mg per ml | Flynn | 2640481 | Jan 2023 to 2025 |
| PSS | Cefalexin | Grans for oral liq 50 mg per ml | Flynn | 2640503 | Jan 2023 to 2025 |
| PSS | Cefazolin | Inj 1 g vial | Cefazolin-AFT | 2391317 | Mar 2024 to 2026 |
| PSS | Cefazolin | Inj 2 g vial | Cefazolin-AFT | 2662876 | Mar 2024 to 2026 |
| PSS | Cefazolin | Inj 500 mg vial | Cefazolin-AFT | 2391325 | Mar 2024 to 2026 |
| PSS | Cefepime | Inj 1 g vial | Cefepime Kabi | 2603381 | Jan 2022 to 2024 |
| PSS | Cefepime | Inj 2 g vial | Cefepime Kabi | 2603411 | Jan 2022 to 2024 |
| PSS | Cefotaxime | Inj 1 g vial | DBL Cefotaxime | 2389762 | Dec 2023 to 2026 |
| PSS | Ceftazidime | Inj 1 g vial | Ceftazidime Kabi | 2581183 | Dec 2023 to 2026 |
| PSS | Ceftriaxone | Inj 1 g vial | Ceftriaxone-AFT | 2428644 | Apr 2023 to 2025 |
| PSS | Ceftriaxone | Inj 2 g vial | Ceftriaxone-AFT | 2653273 | Aug 2023 to 2025 |
| PSS | Ceftriaxone | Inj 500 mg vial | Ceftriaxone-AFT | 2400820 | Apr 2023 to 2025 |
| PSS | Cefuroxime | Inj 1.5 g vial | Cefuroxime Devatis | 2664909 | Jun 2024 to 2026 |
| PSS | Cefuroxime | Inj 750 mg vial | Cefuroxime Devatis | 2664895 | Jun 2024 to 2026 |
| PSS | Celecoxib | Cap 100 mg | Celecoxib Pfizer | 2521164 | Nov 2022 to 2025 |
| PSS | Celecoxib | Cap 200 mg | Celecoxib Pfizer | 2521172 | Nov 2022 to 2025 |
| PSS | Cetirizine hydrochloride | Oral liq 1 mg per ml | Histaclear | 2461625 | Jan 2022 to 2024 |
| PSS | Cetirizine hydrochloride | Tab 10 mg | Zista | 2500728 | Sep 2023 to 2026 |
| PSS | Cetomacrogol | Crm BP, 500 g | Cetomacrogol-AFT | 2615509 | May 2022 to 2024 |
| PSS | Cetomacrogol with glycerol | Crm 90% with glycerol 10% | Evara | 2642778 | Jul 2023 to 2025 |
| PSS | Cetomacrogol with glycerol | Crm 90% with glycerol 10% | Evara | 2642786 | Jul 2023 to 2025 |
| PSS | Chloramphenicol | Eye oint 1% | Devatis | 2576902 | Dec 2022 to 2025 |
| PSS | Chloramphenicol | Eye drops 0.5% | Chlorsig | 335142 | Sep 2023 to 2025 |
| PSS | Chlortalidone [Chlorthalidone] | Tab 25 mg | Hygroton | 2025779 | Apr 2023 to 2025 |
| PSS | Cinacalcet | Tab 30 mg | Cinacalet Devatis | 2615517 | Apr 2022 to 2024 |
| PSS | Cinacalcet | Tab 60 mg | Cinacalet Devatis | 2615525 | Apr 2022 to 2024 |
| PSS | Ciprofloxacin | Eye drops 0.3% | Ciprofloxacin Teva | 2539144 | Nov 2021 to 2024 |
| PSS | Cisplatin | Inj 1 mg per ml, 100 ml vial | DBL Cisplatin | 528048 | Mar 2022 to 2024 |
| PSS | Citalopram hydrobromide | Tab 20 mg | Celapram | 2638738 | Mar 2023 to 2025 |
| PSS | Clarithromycin | Inj 500 mg vial | Klacid IV | 2651904 | Jul 2024 to 2026 |
| HSS | Clarithromycin | Tab 250 mg | Klacid | 2606038 | Feb 2022 to 2027 |
| HSS | Clarithromycin | Tab 500 mg | Klacid | 2605295 | Feb 2022 to 2027 |
| PSS | Clindamycin | Inj 150 mg per ml, 4 ml ampoule | Hameln | 2646595 | Aug 2023 to 2025 |
| PSS | Clobetasol propionate | Crm 0.05% | Dermol | 229059 | Jan 2023 to 2025 |
| PSS | Clobetasol propionate | Oint 0.05% | Dermol | 229040 | Jan 2023 to 2025 |
| PSS | Clobetasol propionate | Scalp app 0.05% | Dermol | 772755 | Jan 2023 to 2025 |
| HSS | Clomipramine hydrochloride | Tab 10 mg | Clomipramine Teva | 2611392 | Feb 2022 to 2024 |
| HSS | Clomipramine hydrochloride | Tab 25 mg | Clomipramine Teva | 2611406 | Feb 2022 to 2024 |
| PSS | Clonidine | Patch 2.5 mg, 100 mcg per day | Mylan | 2523078 | Feb 2024 to 2026 |
| PSS | Clonidine | Patch 5 mg, 200 mcg per day | Mylan | 2523086 | Feb 2024 to 2026 |
| PSS | Clonidine | Patch 7.5 mg, 300 mcg per day | Mylan | 2523094 | Feb 2024 to 2026 |
| PSS | Clonidine hydrochloride | Inj 150 mcg per ml, 1 ml ampoule | Medsurge | 2548445 | Jan 2022 to 2024 |
| PSS | Clonidine hydrochloride | Tab 150 mcg | Catapres | 202274 | Jan 2022 to 2024 |
| PSS | Clonidine hydrochloride | Tab 25 mcg | Clonidine Teva | 2630249 | Nov 2022 to 2025 |
| PSS | Clopidogrel | Tab 75 mg | Arrow - Clopid | 2648954 | May 2023 to 2025 |
| PSS | Clotrimazole | Crm 1% | Clomazol | 2184362 | Apr 2023 to 2025 |
| PSS | Clotrimazole | Vaginal crm 1% with applicator | Clomazol | 2155656 | Apr 2023 to 2025 |
| PSS | Clotrimazole | Vaginal crm 2% with applicator | Clomazol | 2249634 | Apr 2023 to 2025 |
| PSS | Codeine phosphate | Tab 15 mg | Noumed | 2643200 | May 2023 to 2025 |
| PSS | Codeine phosphate | Tab 30 mg | Noumed | 2643219 | Apr 2023 to 2025 |
| PSS | Codeine phosphate | Tab 60 mg | Noumed | 2643227 | Apr 2023 to 2025 |
| PSS | Colchicine | Tab 500 mcg | Colgout | 2200503 | Sep 2022 to 2025 |
| PSS | Colecalciferol | Cap 1.25 mg (50,000 iu) | Vit.D3 | 2523590 | Jun 2024 to 2026 |
| PSS | Compound electrolytes | Powder for oral soln | Electral | 2576937 | Dec 2022 to 2025 |
| PSS | Compound electrolytes with glucose [Dextrose] | Soln with electrolytes | Hydralyte - Lemonade | 2468255 | May 2024 to 2025 |
| PSS | Crotamiton | Crm 10% | Itch-Soothe | 2343614 | Dec 2021 to 2024 |
| PSS | Cyclizine hydrochloride | Tab 50 mg | Nausicalm | 2231220 | Dec 2021 to 2024 |
| PSS | Cyclizine lactate | Inj 50 mg per ml, 1 ml ampoule | Hameln | 2595877 | Dec 2022 to 2025 |
| PSS | Cyclophosphamide | Inj 1 g vial | Endoxan | 2034212 | Dec 2021 to 2024 |
| PSS | Cyclophosphamide | Inj 2 g vial | Endoxan | 2034220 | Dec 2021 to 2024 |
| PSS | Cyclophosphamide | Tab 50 mg | Cyclonex | 2611597 | Jan 2022 to 2024 |
| PSS | Cyproterone acetate | Tab 100 mg | Siterone | 2235862 | Jan 2022 to 2024 |
| PSS | Cyproterone acetate | Tab 50 mg | Siterone | 2220482 | Jan 2022 to 2024 |
| PSS | Cyproterone acetate with ethinyloestradiol | Tab 2 mg with ethinyloestradiol 35 mcg and 7 inert tablets | Ginet | 2455455 | Feb 2024 to 2026 |
| PSS | Dabigatran | Cap 110 mg | Pradaxa | 2319594 | Jul 2024 to 2026 |
| PSS | Dabigatran | Cap 150 mg | Pradaxa | 2389673 | Jul 2024 to 2026 |
| PSS | Dabigatran | Cap 75 mg | Pradaxa | 2319586 | Jul 2024 to 2026 |
| PSS | Daptomycin | Inj 500 mg vial | Daptomycin Dr Reddy's | 2661616 | Jan 2024 to 2025 |
| PSS | Darunavir | Tab 400 mg | Darunavir Viatris | 2626462 | Feb 2024 to 2026 |
| PSS | Darunavir | Tab 600 mg | Darunavir Viatris | 2626470 | Feb 2024 to 2026 |
| PSS | Desmopressin acetate | Nasal spray 10 mcg per dose | Desmopressin-PH&T | 2198231 | Feb 2024 to 2026 |
| PSS | Dexamethasone | Tab 0.5 mg | Dexmethsone | 2490218 | Jan 2022 to 2024 |
| PSS | Dexamethasone | Tab 4 mg | Dexmethsone | 2490226 | Jan 2022 to 2024 |
| PSS | Dexamethasone phosphate | Inj 4 mg per ml, 1 ml ampoule | Hameln | 2451689 | Feb 2023 to 2025 |
| PSS | Dexamethasone phosphate | Inj 4 mg per ml, 2 ml ampoule | Hameln | 2519143 | Feb 2023 to 2025 |
| PSS | Dexamfetamine sulfate | Tab 5 mg | Noumed Dexamfetamine | 2647516 | Jun 2024 to 2025 |
| PSS | Dexmedetomidine | Inj 100 mcg per ml, 2 ml vial | Dexmedetomidine Viatris | 2660008 | May 2024 to 2026 |
| PSS | Diazepam | Tab 2 mg | Arrow-Diazepam | 2327996 | Mar 2024 to 2026 |
| PSS | Diazepam | Tab 5 mg | Arrow-Diazepam | 2328003 | Mar 2024 to 2026 |
| PSS | Diazepam | Rectal tubes 5 mg | Stesolid | 425877 | Feb 2023 to 2025 |
| PSS | Diclofenac sodium | Eye drops 0.1% | Voltaren Ophtha | 781851 | Nov 2021 to 2024 |
| PSS | Diclofenac sodium | Tab EC 25 mg | Diclofenac Sandoz | 2355981 | Jan 2022 to 2024 |
| PSS | Diclofenac sodium | Tab EC 50 mg | Diclofenac Sandoz | 2356007 | Jan 2022 to 2024 |
| PSS | Digoxin | Tab 250 mcg | Lanoxin | 2378078 | Jan 2023 to 2025 |
| PSS | Digoxin | Tab 62.5 mcg | Lanoxin PG | 2377012 | Jan 2023 to 2025 |
| PSS | Dihydrocodeine tartrate | Tab long-acting 60 mg | DHC Continus | 772887 | Dec 2022 to 2025 |
| PSS | Diltiazem hydrochloride | Cap long-acting 120 mg | Diltiazem CD Clinect | 2648172 | Jun 2023 to 2025 |
| HSS | Diltiazem hydrochloride | Cap long-acting 180 mg | Cardizem CD | 254584 | Mar 2022 to 2027 |
| HSS | Diltiazem hydrochloride | Cap long-acting 240 mg | Cardizem CD | 254592 | Mar 2022 to 2027 |
| PSS | Dimethicone | Crm 5% tube | healthE Dimethicone 5% | 2374005 | Dec 2022 to 2025 |
| PSS | Dimethicone | Lotn 4% | healthE Dimethicone 4% Lotion | 2351293 | Dec 2022 to 2025 |
| PSS | Dimethicone | Crm 5% pump bottle | healthE Dimethicone 5% | 2373319 | Dec 2022 to 2025 |
| HSS | Diphtheria, tetanus and pertussis vaccine | Inj 2 IU diphtheria toxoid with 20 IU tetanus toxoid, 8 mcg pertussis toxoid, 8 mcg pertussis filamentous haemagglutinin and 2.5 mcg pertactin in 0.5 ml syringe | Boostrix | 2459418 | Oct 2020 to 2024 |
| HSS | Diphtheria, tetanus, pertussis and polio vaccine | Inj 30 IU diphtheria toxoid with 30IU tetanus toxoid, 25 mcg pertussis toxoid, 25 mcg pertussis filamentous haemagglutinin, 8 mcg pertactin and 80 D-antigen units poliomyelitis virus in 0.5 ml syringe | Infanrix IPV | 2086417 | Oct 2020 to 2024 |
| HSS | Diphtheria, tetanus, pertussis, polio, hepatitis B and haemophilus influenzae type B vaccine | Inj 30 IU diphtheria toxoid with 40 IU tetanus toxoid, 25 mcg pertussis toxoid, 25 mcg pertussis filamentous haemagglutinin, 8 mcg pertactin, 80 D-antigen units poliomyelitis virus, 10 mcg hepatitis B | Infanrix-hexa | 2459396 | Oct 2020 to 2024 |
| PSS | Disulfiram | Tab 200 mg | Antabuse | 524492 | Nov 2021 to 2024 |
| PSS | Dobutamine | Inj 12.5 mg per ml, 20 ml ampoule | Dobutamine-hameln | 2450836 | Dec 2021 to 2024 |
| PSS | Docetaxel | Inj 10 mg per ml, 8 ml vial | DBL Docetaxel | 2440830 | Dec 2023 to 2026 |
| PSS | Docusate sodium | Tab 120 mg | Coloxyl | 252859 | Feb 2024 to 2026 |
| PSS | Docusate sodium | Tab 50 mg | Coloxyl | 252832 | Feb 2024 to 2026 |
| PSS | Docusate sodium with sennosides | Tab 50 mg with sennosides 8 mg | Laxsol | 2069482 | Nov 2022 to 2025 |
| PSS | Domperidone | Tab 10 mg | Domperidone Viatris | 2631903 | Jun 2023 to 2025 |
| PSS | Donepezil hydrochloride | Tab 10 mg | Ipca-Donepezil | 2666898 | Jun 2024 to 2026 |
| PSS | Donepezil hydrochloride | Tab 5 mg | Ipca-Donepezil | 2666871 | Jun 2024 to 2026 |
| PSS | Dopamine hydrochloride | Inj 40 mg per ml, 5 ml ampoule | Max Health Ltd | 2374374 | Jan 2022 to 2024 |
| PSS | Dorzolamide with timolol | Eye drops 2% with timolol 0.5% | Dortimopt | 2398354 | Dec 2021 to 2024 |
| PSS | Doxorubicin hydrochloride | Inj 2 mg per ml, 100 ml vial | Doxorubicin Ebewe | 2224100 | Jan 2022 to 2024 |
| PSS | Droperidol | Inj 2.5 mg per ml, 1 ml ampoule | Droperidol Panpharma | 2527138 | Mar 2023 to 2025 |
| PSS | Emtricitabine with tenofovir disoproxil | Tab 200 mg with tenofovir disoproxil 245 mg (300 mg as a maleate) | Tenofovir Disoproxil Emtricitabine Viatr | 2638088 | Jun 2023 to 2025 |
| PSS | Emulsifying ointment | Oint BP | Jaychem | 2377675 | Feb 2024 to 2026 |
| PSS | Emulsifying ointment | Oint BP, 500 g | Emulsifying Ointment ADE | 2597535 | May 2024 to 2026 |
| PSS | Enalapril maleate | Tab 10 mg | Acetec | 2636492 | Feb 2024 to 2025 |
| PSS | Enalapril maleate | Tab 20 mg | Acetec | 2636506 | Feb 2024 to 2025 |
| PSS | Enalapril maleate | Tab 5 mg | Acetec | 2636484 | Feb 2024 to 2025 |
| PSS | Entacapone | Tab 200 mg | Comtan | 2536471 | Apr 2022 to 2024 |
| PSS | Entecavir | Tab 0.5 mg | Entecavir (Rex) | 2654431 | Mar 2024 to 2026 |
| PSS | Ephedrine | Inj 3 mg per ml, 10 ml syringe | Ephedrine Juno | 2544598 | Jun 2024 to 2026 |
| PSS | Ephedrine | Inj 30 mg per ml, 1 ml ampoule | Max Health | 2402874 | Feb 2024 to 2026 |
| PSS | Epirubicin hydrochloride | Inj 2 mg per ml, 100 ml vial | Epirubicin Ebewe | 2224143 | Jan 2022 to 2024 |
| PSS | Eplerenone | Tab 25 mg | Inspra | 2619512 | Jun 2022 to 2024 |
| PSS | Eplerenone | Tab 50 mg | Inspra | 2555069 | Jun 2022 to 2024 |
| PSS | Eplerenone | Tab 50 mg | Inspra | 2619520 | Jun 2022 to 2024 |
| PSS | Erlotinib | Tab 100 mg | Alchemy | 2641569 | Oct 2024 to 2027 |
| PSS | Erlotinib | Tab 150 mg | Alchemy | 2641550 | Oct 2024 to 2027 |
| PSS | Erythromycin (as lactobionate) | Inj 1 g vial | Erythrocin IV | 2270234 | Dec 2022 to 2025 |
| PSS | Escitalopram | Tab 10 mg | Ipca-Escitalopram | 2661640 | Apr 2024 to 2026 |
| PSS | Escitalopram | Tab 20 mg | Ipca-Escitalopram | 2661659 | Apr 2024 to 2026 |
| HSS | Etanercept | Inj 25 mg vial | Enbrel | 2006561 | Sep 2019 to 2024 |
| HSS | Etanercept | Inj 25 mg autoinjector | Enbrel | 2602113 | Feb 2021 to 2024 |
| HSS | Etanercept | Inj 50 mg autoinjector | Enbrel | 2510456 | Sep 2019 to 2024 |
| HSS | Etanercept | Inj 50 mg syringe | Enbrel | 2382113 | Sep 2019 to 2024 |
| PSS | Ethinyloestradiol with levonorgestrel | Tab 20 mcg with levonorgestrel 100 mcg and 7 inert tablets | Lo-Oralcon 20 ED | 2637111 | Aug 2023 to 2025 |
| PSS | Ethinyloestradiol with levonorgestrel | Tab 30 mcg with levonorgestrel 150 mcg and 7 inert tablets | Oralcon 30 ED | 2637138 | Aug 2023 to 2025 |
| PSS | Exemestane | Tab 25 mg | Pfizer Exemestane | 2500647 | Nov 2023 to 2026 |
| PSS | Ezetimibe | Tab 10 mg | Ezetimibe Sandoz | 2545861 | Dec 2023 to 2026 |
| PSS | Febuxostat | Tab 120 mg | Febuxostat (Teva) | 2670364 | Jun 2024 to 2026 |
| PSS | Febuxostat | Tab 80 mg | Febuxostat (Teva) | 2670356 | Jun 2024 to 2026 |
| PSS | Felodipine | Tab long-acting 10 mg | Felo 10 ER | 2041499 | Jan 2022 to 2024 |
| PSS | Felodipine | Tab long-acting 5 mg | Felo 5 ER | 2041510 | Jan 2022 to 2024 |
| PSS | Fentanyl | Inj 50 mcg per ml, 2 ml ampoule | Boucher and Muir | 2381176 | Apr 2022 to 2024 |
| PSS | Fentanyl | Inj 10 mcg per ml, 100 ml bag | Biomed | 2594137 | Feb 2024 to 2026 |
| PSS | Fentanyl | Inj 50 mcg per ml, 10 ml ampoule | Boucher and Muir | 2381168 | Apr 2022 to 2024 |
| PSS | Fentanyl | Patch 100 mcg per hour | Fentanyl Sandoz | 2472910 | Jan 2022 to 2024 |
| PSS | Fentanyl | Patch 12.5 mcg per hour | Fentanyl Sandoz | 2472872 | Jan 2022 to 2024 |
| PSS | Fentanyl | Patch 25 mcg per hour | Fentanyl Sandoz | 2472880 | Jan 2022 to 2024 |
| PSS | Fentanyl | Patch 50 mcg per hour | Fentanyl Sandoz | 2472899 | Jan 2022 to 2024 |
| PSS | Fentanyl | Patch 75 mcg per hour | Fentanyl Sandoz | 2472902 | Jan 2022 to 2024 |
| PSS | Ferrous fumarate | Tab 200 mg (65 mg elemental) | Ferro-tab | 2162156 | May 2022 to 2024 |
| PSS | Ferrous fumarate with folic acid | Tab 310 mg (100 mg elemental) with folic acid 350 mcg | Ferro-F-Tabs | 2615584 | Aug 2022 to 2024 |
| PSS | Ferrous sulfate | Oral liq 30 mg (6 mg elemental) per ml | Ferodan | 2259087 | Jan 2023 to 2025 |
| PSS | Ferrous sulfate | Tab long-acting 325 mg (105 mg elemental) | Ferrograd | 2534819 | Jan 2023 to 2025 |
| PSS | Filgrastim | Inj 300 mcg in 0.5 ml prefilled syringe | Nivestim | 2561956 | Dec 2021 to 2024 |
| PSS | Filgrastim | Inj 480 mcg in 0.5 ml prefilled syringe | Nivestim | 2561964 | Dec 2021 to 2024 |
| PSS | Finasteride | Tab 5 mg | Ricit | 2522756 | Dec 2023 to 2026 |
| PSS | Flecainide acetate | Cap long-acting 100 mg | Flecainide Controlled Release Teva | 2567113 | Aug 2023 to 2026 |
| PSS | Flecainide acetate | Cap long-acting 200 mg | Flecainide Controlled Release Teva | 2567121 | Aug 2023 to 2026 |
| PSS | Flecainide acetate | Tab 50 mg | Flecainide BNM | 2567695 | Dec 2023 to 2026 |
| PSS | Flucloxacillin | Cap 250 mg | Flucloxacillin-AFT | 2335573 | May 2022 to 2024 |
| PSS | Flucloxacillin | Cap 500 mg | Flucloxacillin-AFT | 2224186 | May 2022 to 2024 |
| PSS | Flucloxacillin | Inj 1 g vial | Flucil | 2523108 | Feb 2024 to 2026 |
| PSS | Flucloxacillin | Inj 250 mg vial | Flucloxin | 331848 | Jul 2024 to 2026 |
| PSS | Flucloxacillin | Inj 500 mg vial | Flucloxin | 331856 | Jul 2024 to 2026 |
| PSS | Flucloxacillin | Grans for oral liq 25 mg per ml | AFT | 2072270 | Jan 2022 to 2024 |
| PSS | Flucloxacillin | Grans for oral liq 25 mg per ml | AFT | 2431424 | Jan 2022 to 2024 |
| PSS | Flucloxacillin | Grans for oral liq 50 mg per ml | AFT | 2072262 | Jan 2022 to 2024 |
| PSS | Flucloxacillin | Grans for oral liq 50 mg per ml | AFT | 2431432 | Jan 2022 to 2024 |
| PSS | Fluconazole | Cap 150 mg | Mylan | 2149079 | Dec 2023 to 2026 |
| PSS | Fluconazole | Cap 200 mg | Mylan | 2149052 | Dec 2023 to 2026 |
| PSS | Fluconazole | Cap 50 mg | Mylan | 2149060 | Dec 2023 to 2026 |
| PSS | Fludarabine phosphate | Inj 50 mg vial | Fludarabine Ebewe | 2386933 | Jan 2023 to 2025 |
| PSS | Fludrocortisone acetate | Tab 100 mcg | Florinef | 204951 | Dec 2022 to 2025 |
| PSS | Flumazenil | Inj 0.1 mg per ml, 5 ml ampoule | Hameln | 2558904 | Feb 2022 to 2024 |
| PSS | Fluorouracil | Inj 50 mg per ml, 20 ml vial | Fluorouracil Accord | 2618435 | Feb 2022 to 2024 |
| PSS | Fluorouracil | Inj 50 mg per ml, 100 ml vial | Fluorouracil Accord | 2618427 | Feb 2022 to 2024 |
| PSS | Fluorouracil sodium | Crm 5% | Efudix | 253065 | Dec 2021 to 2024 |
| PSS | Fluoxetine hydrochloride | Cap 20 mg | Arrow-Fluoxetine | 2450860 | Jun 2023 to 2025 |
| PSS | Fluoxetine hydrochloride | Tab dispersible 20 mg, scored | Fluox | 2618575 | Feb 2023 to 2025 |
| PSS | Fluticasone propionate | Nasal spray 50 mcg per dose | Flixonase Hayfever & Allergy | 2407000 | Dec 2021 to 2024 |
| HSS | Folic acid | Tab 5 mg | Folic Acid Viatris | 2633450 | Mar 2023 to 2027 |
| PSS | Furosemide [Frusemide] | Inj 10 mg per ml, 2 ml ampoule | Furosemide-Baxter | 2599503 | Jan 2023 to 2025 |
| HSS | Furosemide [Frusemide] | Tab 40 mg | IPCA-Frusemide | 2618699 | Mar 2021 to 2024 |
| HSS | Gabapentin | Cap 100 mg | Nupentin | 2422751 | Feb 2022 to 2027 |
| HSS | Gabapentin | Cap 300 mg | Nupentin | 2422778 | Feb 2022 to 2027 |
| HSS | Gabapentin | Cap 400 mg | Nupentin | 2422786 | Feb 2022 to 2027 |
| PSS | Gemcitabine Hydrochloride | Inj 43.3 mg per ml (equivalent to 38 mg per ml gemcitabine), 26.3 ml vial | DBL Gemcitabine | 2521423 | Jun 2024 to 2026 |
| PSS | Glatiramer acetate | Inj 40 mg prefilled syringe | Copaxone | 2545349 | Oct 2022 to 2025 |
| PSS | Glibenclamide | Tab 5 mg | Daonil | 203106 | Jan 2022 to 2024 |
| PSS | Gliclazide | Tab 80 mg | Glizide | 2280647 | Feb 2024 to 2026 |
| PSS | Glipizide | Tab 5 mg | Minidiab | 2091755 | Mar 2022 to 2024 |
| PSS | Glucose [Dextrose] | Inj 50%, 10 ml ampoule | Biomed | 2243296 | Feb 2024 to 2026 |
| PSS | Glucose [Dextrose] | Inj 50%, 90 ml bottle | Biomed | 2245833 | Feb 2024 to 2026 |
| PSS | Glycerol | Suppos 2.8/4.0 g | Lax-suppositories Glycerol | 2637103 | Feb 2023 to 2025 |
| PSS | Glyceryl trinitrate | Oint 0.2% | Rectogesic | 2120313 | Sep 2021 to 2024 |
| PSS | Glycopyrronium bromide | Inj 200 mcg per ml, 1 ml ampoule | Robinul | 2254484 | Sep 2023 to 2025 |
| PSS | Goserelin | Implant 10.8 mg, syringe | Zoladex | 362107 | Apr 2024 to 2026 |
| PSS | Goserelin | Implant 3.6 mg, syringe | Zoladex | 678066 | Apr 2024 to 2026 |
| PSS | Granisetron | Inj 1 mg per ml, 3 ml ampoule | Deva | 2554186 | Feb 2024 to 2026 |
| PSS | Heparin sodium | Inj 5,000 iu per ml, 5 ml vial | Heparin Sodium Panpharma | 2651815 | Jul 2023 to 2025 |
| HSS | Hepatitis A vaccine | Inj 1440 ELISA units in 1 ml syringe | Havrix | 2061937 | Oct 2020 to 2024 |
| HSS | Hepatitis A vaccine | Inj 720 ELISA units in 0.5 ml syringe | Havrix Junior | 793582 | Oct 2020 to 2024 |
| HSS | Hepatitis B recombinant vaccine | Inj 20 mcg per 1 ml prefilled syringe | Engerix-B | 2534533 | Oct 2020 to 2024 |
| HSS | Human papillomavirus (6, 11, 16, 18, 31, 33, 45, 52 and 58) vaccine [HPV] | Inj 270 mcg in 0.5 ml syringe | Gardasil 9 | 2506254 | Oct 2020 to 2024 |
| PSS | Hydrocortisone | Crm 1%, 30 g | Ethics | 2646587 | Apr 2023 to 2025 |
| PSS | Hydrocortisone | Crm 1%, 500 g | Noumed | 2645580 | Aug 2023 to 2025 |
| PSS | Hydrocortisone | Inj 100 mg vial | Solu-Cortef | 265284 | Nov 2021 to 2024 |
| PSS | Hydrocortisone and paraffin liquid and lanolin | Lotn 1% with paraffin liquid 15.9% and lanolin 0.6% | DP Lotn HC | 716294 | Jun 2024 to 2026 |
| PSS | Hydrocortisone butyrate | Oint 0.1% | Locoid | 210382 | Dec 2021 to 2024 |
| PSS | Hydrocortisone butyrate | Milky emul 0.1% | Locoid Crelo | 2017458 | Dec 2021 to 2024 |
| PSS | Hydrocortisone butyrate | Scalp lotn 0.1% | Locoid | 210307 | Dec 2021 to 2024 |
| PSS | Hydrocortisone with miconazole | Crm 1% with miconazole nitrate 2% | Micreme H | 704733 | Dec 2021 to 2024 |
| PSS | Hydroxocobalamin | Inj 1 mg per ml, 1 ml ampoule | Hydroxocobalamin Panpharma | 2637391 | Nov 2022 to 2024 |
| PSS | Hydroxyurea [hydroxycarbamide] | Cap 500 mg | Devatis | 2593246 | Dec 2023 to 2026 |
| PSS | Hyoscine butylbromide | Inj 20 mg, 1 ml ampoule | Spazmol | 2656027 | Dec 2023 to 2026 |
| PSS | Ibuprofen | Oral liq 20 mg per ml | Ethics | 2551985 | Apr 2022 to 2024 |
| HSS | Ibuprofen | Tab 200 mg - 1,000 tablet pack | Relieve | 2526212 | Feb 2021 to 2026 |
| PSS | Ibuprofen | Tab long-acting 800 mg | Brufen SR | 2534320 | Jan 2022 to 2024 |
| PSS | Iloprost | Nebuliser soln 10 mcg per ml, 2 ml | Vebulis | 2643006 | Mar 2023 to 2025 |
| PSS | Imatinib mesilate | Cap 100 mg | Imatinib-Rex | 2594315 | Dec 2023 to 2026 |
| PSS | Imatinib mesilate | Cap 400 mg | Imatinib-Rex | 2594323 | Dec 2023 to 2026 |
| PSS | Indapamide | Tab 2.5 mg | Dapa-Tabs | 2356406 | Feb 2024 to 2026 |
| HSS | Infliximab | Inj 100 mg | Remicade | 2016710 | Sep 2020 to 2025 |
| PSS | Intra-uterine device | IUD 29.1 mm length x 23.2 mm width | Choice TT380 Short | 2467151 | Apr 2023 to 2025 |
| PSS | Intra-uterine device | IUD 33.6 mm length x 29.9 mm width | Choice TT380 Standard | 2467178 | Apr 2023 to 2025 |
| PSS | Intra-uterine device | IUD 35.5 mm length x 19.6 mm width | Choice Load 375 | 2497999 | Apr 2023 to 2025 |
| PSS | Irinotecan hydrochloride | Inj 20 mg per ml, 5 ml vial | Accord | 2621177 | Mar 2022 to 2024 |
| PSS | Isoniazid | Tab 100 mg | PSM | 267473 | Jan 2022 to 2024 |
| PSS | Isoniazid with rifampicin | Tab 150 mg with rifampicin 300 mg | Rifinah | 251240 | Jan 2022 to 2024 |
| PSS | Isosorbide mononitrate | Tab 20 mg | Ismo 20 | 214833 | Feb 2024 to 2026 |
| PSS | Isosorbide mononitrate | Tab long-acting 40 mg | Ismo 40 Retard | 2447355 | Feb 2024 to 2026 |
| PSS | Isosorbide mononitrate | Tab long-acting 60 mg | Duride | 2202964 | Feb 2024 to 2026 |
| PSS | Isotretinoin | Cap 10 mg | Oratane | 2400286 | Mar 2022 to 2024 |
| PSS | Isotretinoin | Cap 20 mg | Oratane | 2400278 | Mar 2022 to 2024 |
| PSS | Isotretinoin | Cap 5 mg | Oratane | 2339161 | Mar 2022 to 2024 |
| PSS | Ispaghula (psyllium) husk | Powder for oral soln | Konsyl-D | 2358727 | Feb 2024 to 2026 |
| PSS | Ketoconazole | Shampoo 2% | Sebizole | 461504 | May 2024 to 2026 |
| HSS | Labetalol | Tab 100 mg | Trandate | 2582155 | Sep 2020 to 2024 |
| HSS | Labetalol | Tab 200 mg | Trandate | 2582163 | Sep 2020 to 2024 |
| PSS | Lactulose | Oral liq 10 g per 15 ml | Laevolac | 2440210 | Apr 2023 to 2025 |
| PSS | Lamivudine | Tab 100 mg | Zetlam | 2399369 | Feb 2024 to 2026 |
| PSS | Lamivudine | Tab 150 mg | Lamivudine Viatris | 2638045 | Feb 2024 to 2026 |
| PSS | Lansoprazole | Cap 15 mg | Lanzol Relief | 2482533 | Dec 2021 to 2024 |
| PSS | Lansoprazole | Cap 30 mg | Lanzol Relief | 2482541 | Dec 2021 to 2024 |
| PSS | Latanoprost | Eye drops 0.005% | Teva | 2553139 | Feb 2022 to 2024 |
| PSS | Latanoprost with timolol | Eye drops 0.005% with timolol 0.5% | Arrow - Lattim | 2597861 | Mar 2024 to 2026 |
| PSS | Leflunomide | Tab 10 mg | Arava | 306843 | Dec 2023 to 2026 |
| PSS | Leflunomide | Tab 20 mg | Arava | 369470 | Dec 2023 to 2026 |
| PSS | Letrozole | Tab 2.5 mg | Letrole | 2474425 | Jan 2022 to 2024 |
| PSS | Letrozole | Tab 2.5 mg | Letrole | 2656655 | Jan 2022 to 2024 |
| PSS | Levomepromazine hydrochloride | Inj 25 mg per ml, 1 ml ampoule | Wockhardt | 2501902 | Apr 2023 to 2025 |
| HSS | Levonorgestrel | Intra-uterine device 52 mg | Mirena | 2013908 | Nov 2023 to 31~Oct~2024 |
| HSS | Levonorgestrel | Intra-uterine device 13.5 mg | Jaydess | 2474891 | Nov 2023 to 31~Oct~2024 |
| PSS | Levonorgestrel | Subdermal implant (2 x 75 mg rods) | Jadelle | 2265532 | Dec 2023 to 2026 |
| PSS | Levonorgestrel | Tab 1.5 mg | Levonorgestrel BNM | 2645424 | Jun 2023 to 2025 |
| PSS | Lidocaine [Lignocaine] hydrochloride | Gel 2%, 11 ml urethral syringe | Instillagel Lido | 2580497 | Jan 2023 to 2025 |
| PSS | Lidocaine [Lignocaine] hydrochloride | Spray 10% | Xylocaine | 761125 | Jan 2023 to 2025 |
| PSS | Lidocaine [Lignocaine] hydrochloride with adrenaline | Inj 1% with adrenaline 1:100,000, 5 ml ampoule | Xylocaine | 2120577 | Jan 2023 to 2025 |
| PSS | Linezolid | Inj 2 mg per ml, 300 ml bottle | Linezolid Kabi | 2556766 | Dec 2021 to 2024 |
| PSS | Linezolid | Tab 600 mg | Zyvox | 2058758 | Dec 2021 to 2024 |
| PSS | Lisinopril | Tab 10 mg | Ethics Lisinopril | 2352443 | Oct 2022 to 2025 |
| PSS | Lisinopril | Tab 10 mg | Teva Lisinopril | 2643677 | Oct 2022 to 2025 |
| PSS | Lisinopril | Tab 20 mg | Ethics Lisinopril | 2352451 | Oct 2022 to 2025 |
| PSS | Lisinopril | Tab 20 mg | Teva Lisinopril | 2643685 | Oct 2022 to 2025 |
| PSS | Lisinopril | Tab 5 mg | Ethics Lisinopril | 2352435 | Oct 2022 to 2025 |
| PSS | Lisinopril | Tab 5 mg | Teva Lisinopril | 2643669 | Oct 2022 to 2025 |
| PSS | Lithium carbonate | Tab long-acting 400 mg | Priadel | 260851 | Sep 2021 to 2024 |
| PSS | Loperamide hydrochloride | Cap 2 mg | Diamide Relief | 2365545 | Jan 2023 to 2025 |
| PSS | Lopinavir with ritonavir | Tab 100 mg with ritonavir 25 mg | Lopinavir/Ritonavir Mylan | 2613530 | Feb 2022 to 2024 |
| PSS | Lopinavir with ritonavir | Tab 200 mg with ritonavir 50 mg | Lopinavir/Ritonavir Mylan | 2613549 | Feb 2022 to 2024 |
| PSS | Loratadine | Tab 10 mg | Lorafix | 2443996 | Feb 2023 to 2025 |
| PSS | Lorazepam | Tab 1 mg | Ativan | 2139022 | Dec 2021 to 2024 |
| PSS | Lorazepam | Tab 2.5 mg | Ativan | 250120 | Dec 2021 to 2024 |
| PSS | Losartan potassium | Tab 100 mg | Losartan Actavis | 2466880 | Mar 2024 to 2026 |
| PSS | Losartan potassium | Tab 12.5 mg | Losartan Actavis | 2466856 | Mar 2024 to 2026 |
| PSS | Losartan potassium | Tab 25 mg | Losartan Actavis | 2466864 | Mar 2024 to 2026 |
| PSS | Losartan potassium | Tab 50 mg | Losartan Actavis | 2466872 | Mar 2024 to 2026 |
| PSS | Losartan potassium with hydrochlorothiazide | Tab 50 mg with hydrochlorothiazide 12.5 mg | Arrow-Losartan & Hydrochlorothiazide | 2390620 | Jan 2023 to 2025 |
| PSS | Macrogol 3350 with potassium chloride and sodium chloride | Powder for oral soln 755.68 mg with potassium chloride 10.55 mg, sodium chloride 37.33 mg and sodium sulphate 80.62 mg per g, 70 g sachet | Glycoprep Orange | 2637987 | Aug 2022 to 2024 |
| PSS | Macrogol 3350 with potassium chloride and sodium chloride | Powder for oral soln 755.68 mg with potassium chloride 10.55 mg, sodium chloride 37.33 mg and sodium sulphate 80.62 mg per g, 70 g sachet | Glycoprep Orange | 2637995 | Aug 2022 to 2024 |
| PSS | Macrogol 3350 with potassium chloride and sodium chloride with/without sodium sulfate, sodium ascorbate, ascorbic acid | Powd for oral soln 100g with potassium chloride 1g, sodium chloride 2g and sodium sulfate 9g per sach(1), powd for oral soln 40g with potassium chloride 1.2g and sodium chloride 3.2g per sach(1) and powd for oral soln ascorbic acid 7.54g and sodium ascorbate 48.11g per sach(1) | Plenvu | 2569671 | Oct 2023 to 2026 |
| PSS | Macrogol 3350 with potassium chloride, sodium bicarbonate and sodium chloride | Powder for oral soln 13.125 g with potassium chloride 46.6 mg, sodium bicarbonate 178.5 mg and sodium chloride 350.7 mg | Molaxole | 2519887 | Feb 2024 to 2026 |
| PSS | Magnesium sulphate | Inj 2 mmol per ml, 5 ml ampoule | Martindale | 2406438 | Jun 2024 to 2026 |
| HSS | Measles, mumps and rubella vaccine | Injection, measles virus 1,000 CCID50, mumps virus 5,012 CCID50, Rubella virus 1,000 CCID50; prefilled syringe/ampoule of diluent 0.5 ml | Priorix | 2509369 | Oct 2020 to 2024 |
| PSS | Mebendazole | Tab 100 mg | Vermox | 258040 | Jan 2022 to 2024 |
| PSS | Mebeverine hydrochloride | Tab 135 mg | Colofac | 2535297 | Dec 2023 to 2026 |
| PSS | Melatonin | Tab modified-release 2 mg | Vigisom | 2612593 | Apr 2022 to 2024 |
| PSS | Melphalan | Inj 50 mg vial | Melpha | 2647699 | Dec 2023 to 2026 |
| PSS | Mercaptopurine | Tab 50 mg | Puri-nethol | 261270 | Dec 2022 to 2025 |
| PSS | Meropenem | Inj 1 g vial | Meropenem-AFT | 2591316 | Jun 2024 to 2026 |
| PSS | Meropenem | Inj 500 mg vial | Meropenem-AFT | 2591308 | Jun 2024 to 2026 |
| PSS | Metaraminol | Inj 10 mg per ml, 1 ml ampoule | Torbay | 2482983 | Feb 2024 to 2026 |
| HSS | Metformin hydrochloride | Tab immediate-release 500 mg | Metformin Viatris | 2628031 | Mar 2023 to 2027 |
| HSS | Metformin hydrochloride | Tab immediate-release 850 mg | Metformin Viatris | 2628058 | Aug 2023 to 2027 |
| PSS | Methadone hydrochloride | Oral liq 10 mg per ml | Biodone Extra Forte | 412325 | Jan 2022 to 2024 |
| PSS | Methadone hydrochloride | Oral liq 2 mg per ml | Biodone | 361372 | Jan 2022 to 2024 |
| PSS | Methadone hydrochloride | Oral liq 5 mg per ml | Biodone Forte | 412341 | Jan 2022 to 2024 |
| PSS | Methadone hydrochloride | Tab 5 mg | Methadone BNM | 2639823 | Feb 2023 to 2025 |
| PSS | Methenamine (Hexamine) hippurate | Tab 1 g | Hiprex | 209538 | Feb 2023 to 2025 |
| PSS | Methenamine (Hexamine) hippurate | Tab 1 g | Hiprex | 2671077 | Feb 2023 to 2025 |
| PSS | Methotrexate | Inj 100 mg per ml, 50 ml vial | Methotrexate Ebewe | 2215683 | Dec 2023 to 2026 |
| PSS | Methotrexate | Tab 10 mg | Trexate | 2537079 | Jan 2022 to 2024 |
| PSS | Methotrexate | Tab 2.5 mg | Trexate | 2537060 | Jan 2022 to 2024 |
| PSS | Methylprednisolone aceponate | Crm 0.1% | Advantan | 389439 | Feb 2024 to 2026 |
| PSS | Methylprednisolone aceponate | Oint 0.1% | Advantan | 388874 | Feb 2024 to 2026 |
| PSS | Metoclopramide hydrochloride | Inj 5 mg per ml, 2 ml ampoule | Baxter | 2625873 | Dec 2022 to 2025 |
| PSS | Metoclopramide hydrochloride | Tab 10 mg | Metoclopramide Actavis 10 | 2528878 | Mar 2024 to 2026 |
| PSS | Metoprolol succinate | Tab long-acting 190 mg | Myloc CR | 2650738 | Apr 2024 to 2026 |
| PSS | Metoprolol succinate | Tab long-acting 23.75 mg | Myloc CR | 2650681 | Apr 2024 to 2026 |
| PSS | Metoprolol succinate | Tab long-acting 47.5 mg | Myloc CR | 2650703 | Apr 2024 to 2026 |
| PSS | Metoprolol succinate | Tab long-acting 95 mg | Myloc CR | 2650711 | Apr 2024 to 2026 |
| HSS | Metoprolol tartrate | Tab 100 mg | IPCA-Metoprolol | 2618680 | Mar 2022 to 2027 |
| HSS | Metoprolol tartrate | Tab 50 mg | IPCA-Metoprolol | 2618672 | Mar 2022 to 2027 |
| PSS | Metronidazole | Inj 5 mg per ml, 100 ml bag | Baxter | 2548305 | Dec 2023 to 2026 |
| PSS | Miconazole | Oral gel 20 mg per g | Decozol | 2405008 | Dec 2021 to 2024 |
| PSS | Miconazole nitrate | Crm 2% | Multichem | 2184354 | May 2024 to 2026 |
| PSS | Midazolam | Inj 1 mg per ml, 5 ml ampoule | Mylan Midazolam | 2474468 | Jan 2022 to 2024 |
| PSS | Midazolam | Inj 5 mg per ml, 3 ml ampoule | Mylan Midazolam | 2474476 | Jan 2022 to 2024 |
| PSS | Midodrine | Tab 2.5 mg | Midodrine Medsurge | 2632063 | Aug 2023 to 2024 |
| PSS | Midodrine | Tab 5 mg | Midodrine Medsurge | 2632071 | Aug 2023 to 2024 |
| PSS | Milrinone | Inj 1 mg per ml, 10 ml ampoule | Milrinone-Baxter | 2603047 | Dec 2021 to 2024 |
| HSS | Mirtazapine | Tab 30 mg | Noumed | 2616084 | Jan 2022 to 2024 |
| HSS | Mirtazapine | Tab 30 mg | Noumed | 2678802 | Jan 2022 to 2024 |
| HSS | Mirtazapine | Tab 45 mg | Noumed | 2616092 | Jan 2022 to 2024 |
| HSS | Mirtazapine | Tab 45 mg | Noumed | 2678810 | Jan 2022 to 2024 |
| PSS | Moclobemide | Tab 150 mg | Aurorix | 2602385 | Jan 2022 to 2024 |
| PSS | Moclobemide | Tab 300 mg | Aurorix | 2602393 | Jan 2022 to 2024 |
| PSS | Modafinil | Tab 100 mg | Modavigil | 2560615 | Mar 2022 to 2024 |
| PSS | Mometasone furoate | Crm 0.1% | Elocon Alcohol Free | 218375 | Feb 2022 to 2024 |
| PSS | Mometasone furoate | Crm 0.1% | Elocon Alcohol Free | 2395738 | Feb 2022 to 2024 |
| PSS | Mometasone furoate | Oint 0.1% | Elocon | 218383 | Feb 2022 to 2024 |
| PSS | Mometasone furoate | Oint 0.1% | Elocon | 2395746 | Feb 2022 to 2024 |
| PSS | Mometasone furoate | Lotn 0.1% | Elocon | 2177633 | Feb 2022 to 2024 |
| PSS | Montelukast | Tab 10 mg | Montelukast Viatris | 2643634 | Sep 2023 to 2025 |
| PSS | Montelukast | Tab 4 mg | Montelukast Viatris | 2643618 | Sep 2023 to 2025 |
| PSS | Montelukast | Tab 5 mg | Montelukast Viatris | 2643626 | Jul 2023 to 2025 |
| PSS | Morphine sulphate | Cap long-acting 10 mg | m-Eslon | 2106469 | Apr 2023 to 2025 |
| PSS | Morphine sulphate | Cap long-acting 100 mg | m-Eslon | 2106507 | Apr 2023 to 2025 |
| PSS | Morphine sulphate | Cap long-acting 30 mg | m-Eslon | 2106485 | Apr 2023 to 2025 |
| PSS | Morphine sulphate | Cap long-acting 60 mg | m-Eslon | 2106493 | Apr 2023 to 2025 |
| PSS | Morphine sulphate | Inj 1 mg per ml, 100 ml bag | Biomed | 2526034 | Feb 2024 to 2026 |
| PSS | Morphine sulphate | Inj 1 mg per ml, 10 ml syringe | Biomed | 2526018 | Feb 2024 to 2026 |
| PSS | Morphine sulphate | Inj 1 mg per ml, 50 ml syringe | Biomed | 2526026 | Feb 2024 to 2026 |
| PSS | Morphine sulphate | Inj 10 mg per ml, 1 ml ampoule | Medsurge | 2602458 | Mar 2023 to 2025 |
| PSS | Morphine sulphate | Inj 15 mg per ml, 1 ml ampoule | Medsurge | 2602466 | Mar 2023 to 2025 |
| PSS | Morphine sulphate | Inj 30 mg per ml, 1 ml ampoule | Medsurge | 2602474 | Mar 2023 to 2025 |
| PSS | Morphine sulphate | Inj 5 mg per ml, 1 ml ampoule | Medsurge | 2602431 | Mar 2023 to 2025 |
| PSS | Moxifloxacin | Inj 1.6 mg per ml, 250 ml bottle | Moxifloxacin Kabi | 2577062 | Feb 2024 to 2026 |
| PSS | Multivitamins | Tab (BPC cap strength) | Mvite | 2642247 | Feb 2023 to 2025 |
| HSS | Nadolol | Tab 40 mg | Nadolol BNM | 2621118 | Mar 2022 to 2024 |
| HSS | Nadolol | Tab 40 mg | Nadolol BNM | 2647540 | Mar 2022 to 2024 |
| HSS | Nadolol | Tab 80 mg | Nadolol BNM | 2621126 | Mar 2022 to 2024 |
| HSS | Nadolol | Tab 80 mg | Nadolol BNM | 2647559 | Mar 2022 to 2024 |
| PSS | Naloxone hydrochloride | Inj 400 mcg per ml, 1 ml ampoule | Hameln | 2634090 | Feb 2023 to 2024 |
| PSS | Naltrexone hydrochloride | Tab 50 mg | Naltraccord | 2380374 | Dec 2023 to 2026 |
| PSS | Naproxen | Tab long-acting 1 g | Naprosyn SR 1000 | 2518619 | Jan 2022 to 2024 |
| PSS | Naproxen | Tab 250 mg | Noflam 250 | 319333 | Jan 2022 to 2024 |
| PSS | Naproxen | Tab 250 mg | Noflam 250 | 2654458 | Jan 2022 to 2024 |
| PSS | Naproxen | Tab 500 mg | Noflam 500 | 323071 | Jan 2022 to 2024 |
| PSS | Naproxen | Tab 500 mg | Noflam 500 | 2654466 | Jan 2022 to 2024 |
| PSS | Naproxen | Tab long-acting 750 mg | Naprosyn SR 750 | 2518627 | Jan 2022 to 2024 |
| PSS | Neostigmine metilsulfate | Inj 2.5 mg per ml, 1 ml ampoule | Max Health | 2599996 | Mar 2022 to 2024 |
| PSS | Neostigmine metilsulfate with glycopyrronium bromide | Inj 2.5 mg with glycopyrronium bromide 0.5 mg per ml, 1 ml ampoule | Max Health | 2444097 | Dec 2021 to 2024 |
| PSS | Nevirapine | Tab 200 mg | Nevirapine Alphapharm | 2404354 | Jan 2022 to 2024 |
| PSS | Nicorandil | Tab 10 mg | Max Health | 2669242 | May 2024 to 2025 |
| PSS | Nicorandil | Tab 20 mg | Max Health | 2669250 | May 2024 to 2025 |
| PSS | Nimodipine | Inj 0.2 mg per ml, 50 ml vial | Nimotop | 2663937 | May 2024 to 2025 |
| PSS | Nimodipine | Tab 30 mg | Nimotop | 818461 | Dec 2022 to 2025 |
| PSS | Nitrofurantoin | Cap modified-release 100 mg | Macrobid | 2493624 | Dec 2023 to 2026 |
| PSS | Nitrofurantoin | Tab 100 mg | Nifuran | 254754 | Dec 2022 to 2024 |
| PSS | Nitrofurantoin | Tab 50 mg | Nifuran | 254738 | Dec 2022 to 2024 |
| PSS | Noradrenaline | Inj 1 mg per ml, 4 ml ampoule | Noradrenaline BNM | 2519879 | Feb 2024 to 2025 |
| PSS | Norethisterone | Tab 350 mcg | Noriday 28 | 398322 | Mar 2022 to 2024 |
| PSS | Nortriptyline hydrochloride | Tab 10 mg | Norpress | 2090678 | May 2023 to 2025 |
| PSS | Nortriptyline hydrochloride | Tab 25 mg | Norpress | 2312441 | May 2023 to 2025 |
| PSS | Nystatin | Vaginal crm 100,000 u per 5 g with applicator(s) | Nilstat | 254908 | Feb 2024 to 2026 |
| PSS | Nystatin | Oral liquid 100,000 u per ml | Nilstat | 254851 | Feb 2024 to 2026 |
| PSS | Octreotide | Inj 100 mcg per ml, 1 ml ampoule | Max Health | 2629518 | Jun 2022 to 2024 |
| PSS | Octreotide | Inj depot 10 mg prefilled syringe | Octreotide Depot Teva | 2615320 | Mar 2022 to 2024 |
| PSS | Octreotide | Inj depot 20 mg prefilled syringe | Octreotide Depot Teva | 2615339 | Mar 2022 to 2024 |
| PSS | Octreotide | Inj depot 30 mg prefilled syringe | Octreotide Depot Teva | 2615347 | Mar 2022 to 2024 |
| PSS | Octreotide | Inj 50 mcg per ml, 1 ml ampoule | Max Health | 2629534 | Jun 2022 to 2024 |
| PSS | Octreotide | Inj 500 mcg per ml, 1 ml ampoule | Max Health | 2629526 | Jun 2022 to 2024 |
| PSS | Oestriol | Crm 1 mg per g with applicator | Ovestin | 767441 | Feb 2024 to 2026 |
| PSS | Oestriol | Pessaries 500 mcg | Ovestin | 767468 | Feb 2024 to 2026 |
| PSS | Oestriol | Tab 2 mg | Ovestin | 767476 | Feb 2024 to 2026 |
| PSS | Oil in water emulsion | Crm, 500 g | Fatty Cream AFT | 2627426 | Sep 2022 to 2025 |
| PSS | Oil in water emulsion | Crm, 100 g | healthE Fatty Cream | 2341034 | Aug 2022 to 2024 |
| PSS | Olanzapine | Tab 10 mg | Zypine | 2439875 | Aug 2024 to 2026 |
| PSS | Olanzapine | Tab 10 mg | Zypine | 2651092 | Aug 2024 to 2026 |
| PSS | Olanzapine | Tab orodispersible 10 mg | Zypine ODT | 2439840 | Feb 2024 to 2026 |
| PSS | Olanzapine | Tab 2.5 mg | Zypine | 2439859 | Aug 2024 to 2026 |
| PSS | Olanzapine | Tab 2.5 mg | Zypine | 2651076 | Aug 2024 to 2026 |
| PSS | Olanzapine | Tab 5 mg | Zypine | 2439867 | Aug 2024 to 2026 |
| PSS | Olanzapine | Tab 5 mg | Zypine | 2651084 | Aug 2024 to 2026 |
| PSS | Olanzapine | Tab orodispersible 5 mg | Zypine ODT | 2439832 | Feb 2024 to 2026 |
| PSS | Olopatadine | Eye drops 0.1% | Olopatadine Teva | 2588048 | Dec 2022 to 2025 |
| PSS | Omeprazole | Cap 10 mg | Omeprazole actavis 10 | 2604930 | Mar 2024 to 2026 |
| PSS | Omeprazole | Cap 20 mg | Omeprazole actavis 20 | 2604949 | Mar 2024 to 2026 |
| PSS | Omeprazole | Cap 40 mg | Omeprazole actavis 40 | 2604957 | Mar 2024 to 2026 |
| PSS | Omeprazole | Inj 40 mg vial | Omezol IV | 2503387 | Jan 2023 to 2025 |
| PSS | Omeprazole | Inj 40 mg ampoule with diluent | Dr Reddy's Omeprazole | 2310201 | Jan 2023 to 2025 |
| PSS | Ondansetron | Inj 2 mg per ml, 2 ml ampoule | Ondansetron-AFT | 2604752 | Mar 2023 to 2025 |
| PSS | Ondansetron | Inj 2 mg per ml, 4 ml ampoule | Ondansetron-AFT | 2604760 | Mar 2023 to 2025 |
| PSS | Ondansetron | Tab 4 mg | Periset | 2648024 | Aug 2023 to 2025 |
| PSS | Ondansetron | Tab dispersible 4 mg | Periset ODT | 2656868 | Mar 2024 to 2026 |
| PSS | Ondansetron | Tab 8 mg | Periset | 2648032 | Aug 2023 to 2025 |
| PSS | Ondansetron | Tab dispersible 8 mg | Periset ODT | 2656876 | Mar 2024 to 2026 |
| PSS | Ornidazole | Tab 500 mg | Arrow-Ornidazole | 2385325 | Dec 2021 to 2024 |
| PSS | Orphenadrine citrate | Tab 100 mg | Norflex | 2645564 | Jan 2022 to 2024 |
| PSS | Oxaliplatin | Inj 5 mg per ml, 20 ml vial | Alchemy Oxaliplatin | 2654830 | Oct 2023 to 2024 |
| PSS | Oxycodone hydrochloride | Cap immediate-release 10 mg | OxyNorm | 2179768 | Dec 2021 to 2024 |
| PSS | Oxycodone hydrochloride | Cap immediate-release 20 mg | OxyNorm | 2179776 | Dec 2021 to 2024 |
| PSS | Oxycodone hydrochloride | Cap immediate-release 5 mg | OxyNorm | 2179741 | Dec 2021 to 2024 |
| PSS | Oxycodone hydrochloride | Inj 10 mg per ml, 1 ml ampoule | Hameln | 2631172 | Jul 2022 to 2024 |
| PSS | Oxycodone hydrochloride | Inj 10 mg per ml, 2 ml ampoule | Hameln | 2631180 | Jul 2022 to 2024 |
| PSS | Oxycodone hydrochloride | Inj 50 mg per ml, 1 ml ampoule | Hameln | 2631199 | Jul 2022 to 2024 |
| PSS | Oxycodone hydrochloride | Oral liq 5 mg per 5 ml | OxyNorm | 2243687 | Sep 2021 to 2024 |
| PSS | Oxycodone hydrochloride | Tab controlled-release 10 mg | Oxycodone Sandoz | 2559722 | Jun 2022 to 2024 |
| PSS | Oxycodone hydrochloride | Tab controlled-release 20 mg | Oxycodone Sandoz | 2559730 | Jun 2022 to 2024 |
| PSS | Oxycodone hydrochloride | Tab controlled-release 40 mg | Oxycodone Sandoz | 2559749 | Jun 2022 to 2024 |
| PSS | Oxycodone hydrochloride | Tab controlled-release 5 mg | Oxycodone Sandoz | 2559714 | Jun 2022 to 2024 |
| PSS | Oxycodone hydrochloride | Tab controlled-release 80 mg | Oxycodone Sandoz | 2559757 | Jun 2022 to 2024 |
| PSS | Oxytocin | Inj 10 iu per ml, 1 ml ampoule | Oxytocin BNM | 2577046 | Jun 2023 to 2025 |
| PSS | Oxytocin | Inj 5 iu per ml, 1 ml ampoule | Oxytocin BNM | 2448211 | Jun 2023 to 2025 |
| PSS | Oxytocin with ergometrine maleate | Inj 5 iu with ergometrine maleate 500 mcg per ml, 1 ml ampoule | Syntometrine | 256269 | Dec 2022 to 2025 |
| PSS | Paclitaxel | Inj 6 mg per ml, 16.7 ml vial | Anzatax | 2271834 | Aug 2024 to 2026 |
| PSS | Paclitaxel | Inj 6 mg per ml, 50 ml vial | Anzatax | 2271818 | Aug 2024 to 2026 |
| PSS | Pancreatic enzyme | Cap pancreatin 150 mg (amylase 8,000 Ph Eur U, lipase 10,000 Ph Eur U, total protease 600 Ph Eur U) | Creon 10000 | 2535300 | Jun 2022 to 2024 |
| PSS | Pancreatic enzyme | Cap pancreatin 300 mg (amylase 18,000 Ph Eur U, lipase 25,000 Ph Eur U, total protease 1,000 Ph Eur U) | Creon 25000 | 2535319 | Jun 2022 to 2024 |
| PSS | Pantoprazole | Tab EC 20 mg | Panzop Relief | 2637146 | Dec 2023 to 2025 |
| PSS | Pantoprazole | Tab EC 40 mg | Panzop Relief | 2637154 | Dec 2023 to 2025 |
| PSS | Paracetamol | Oral liq 120 mg per 5 ml | Paracetamol (Ethics) | 2650665 | Jun 2023 to 2025 |
| PSS | Paracetamol | Oral liq 250 mg per 5 ml | Pamol | 2643650 | Apr 2023 to 2025 |
| PSS | Paracetamol | Suppos 125 mg | Gacet | 2482711 | Feb 2024 to 2026 |
| PSS | Paracetamol | Suppos 250 mg | Gacet | 2482738 | Feb 2024 to 2026 |
| PSS | Paracetamol | Suppos 500 mg | Gacet | 2552663 | Feb 2024 to 2026 |
| HSS | Paracetamol | Tab 500 mg - blister pack - 1,000 tablet pack | Pacimol | 2612712 | Feb 2022 to 2026 |
| HSS | Paracetamol | Tab 500 mg - bottle pack | Noumed Paracetamol | 2611430 | Feb 2022 to 2026 |
| PSS | Paracetamol with codeine | Tab paracetamol 500 mg with codeine phosphate 8 mg | Paracetamol + Codeine (Relieve) | 2461234 | Jan 2023 to 2025 |
| PSS | Paraffin | Oint liquid paraffin 50% with white soft paraffin 50% | White Soft Liquid Paraffin AFT | 2639114 | May 2023 to 2025 |
| PSS | Paraffin | White soft, | EVARA White Soft Paraffin | 2664178 | Jun 2024 to 2026 |
| PSS | Paroxetine | Tab 20 mg | Loxamine | 2626799 | Jan 2023 to 2025 |
| PSS | Pegfilgrastim | Inj 6 mg per 0.6 ml syringe | Ziextenzo | 2643340 | Jun 2023 to 2025 |
| PSS | Perindopril | Tab 2 mg | Coversyl | 2603942 | Jan 2022 to 2024 |
| PSS | Perindopril | Tab 4 mg | Coversyl | 2603950 | Jan 2022 to 2024 |
| PSS | Permethrin | Lotn 5% | A-Scabies | 2332027 | Feb 2024 to 2026 |
| PSS | Pethidine hydrochloride | Tab 50 mg | Noumed Pethidine | 2645599 | Aug 2023 to 2025 |
| PSS | Phenobarbitone | Tab 15 mg | Noumed Phenobarbitone | 2647524 | Aug 2024 to 2025 |
| PSS | Phenobarbitone | Tab 30 mg | Noumed Phenobarbitone | 2647532 | Dec 2023 to 2025 |
| PSS | Phenoxymethylpenicillin [Penicillin V] | Cap 250 mg | Cilicaine VK | 2602865 | Jan 2022 to 2024 |
| PSS | Phenoxymethylpenicillin [Penicillin V] | Cap 500 mg | Cilicaine VK | 2602873 | Jan 2022 to 2024 |
| PSS | Phenoxymethylpenicillin [Penicillin V] | Grans for oral liq 125 mg per 5 ml | AFT | 2029219 | Jan 2023 to 2025 |
| PSS | Phenoxymethylpenicillin [Penicillin V] | Grans for oral liq 250 mg per 5 ml | AFT | 2029227 | Jan 2023 to 2025 |
| PSS | Pimecrolimus | Crm 1% | Elidel | 2098873 | Feb 2024 to 2026 |
| PSS | Pine tar with trolamine laurilsulfate and fluorescein | Soln 2.3% with trolamine laurilsulfate and fluorescein sodium | Pinetarsol | 307661 | Feb 2024 to 2026 |
| PSS | Pioglitazone | Tab 15 mg | Vexazone | 2479435 | Jan 2022 to 2024 |
| PSS | Pioglitazone | Tab 30 mg | Vexazone | 2479443 | Jan 2022 to 2024 |
| PSS | Pioglitazone | Tab 45 mg | Vexazone | 2479451 | Jan 2022 to 2024 |
| PSS | Piperacillin with tazobactam | Inj 4 g with tazobactam 0.5 g vial | PipTaz-AFT | 2529866 | Feb 2023 to 2025 |
| HSS | Pneumococcal (PCV10) conjugate vaccine | inj 1 mcg of pneumococcal polysaccharide serotypes 1, 5, 6B, 7F, 9V, 14 and 23F; 3 mcg of pneumococcal polysaccharide serotypes 4, 18C and 19F in 0.5 ml prefilled syringe | Synflorix | 2404729 | Oct 2020 to 2024 |
| HSS | Pneumococcal (PPV23) polysaccharide vaccine | Inj 575 mcg in 0.5 ml prefilled syringe (25 mcg of each 23 pneumococcal serotype) | Pneumovax 23 | 2478838 | Oct 2020 to 2024 |
| HSS | Poliomyelitis vaccine | Inj 80 D-antigen units in 0.5 ml syringe | IPOL | 216909 | Oct 2020 to 2024 |
| PSS | Poloxamer | Oral drops 10% | Coloxyl | 252816 | Feb 2024 to 2026 |
| PSS | Posaconazole | Oral liq 40 mg per ml | Devatis | 2645181 | May 2023 to 2025 |
| PSS | Posaconazole | Tab modified-release 100 mg | Posaconazole Juno | 2631008 | Apr 2023 to 2025 |
| PSS | Potassium iodate | Tab 253 mcg (150 mcg elemental iodine) | NeuroTabs | 2439964 | Feb 2024 to 2026 |
| PSS | Povidone-iodine | Soln 10% | Riodine | 777447 | Mar 2022 to 2024 |
| PSS | Pramipexole hydrochloride | Tab 0.25 mg | Ramipex | 2450534 | Dec 2022 to 2025 |
| PSS | Pramipexole hydrochloride | Tab 1 mg | Ramipex | 2450542 | Dec 2022 to 2025 |
| PSS | Pravastatin | Tab 20 mg | Clinect | 2665204 | May 2024 to 2026 |
| PSS | Pravastatin | Tab 40 mg | Clinect | 2665212 | May 2024 to 2026 |
| PSS | Prednisolone | Oral liq 5 mg per ml | Redipred | 317659 | Dec 2021 to 2024 |
| PSS | Prochlorperazine | Tab 5 mg | Nausafix | 2528886 | Mar 2024 to 2026 |
| PSS | Progesterone | Cap 100 mg | Utrogestan | 2086905 | May 2023 to 2025 |
| PSS | Promethazine hydrochloride | Tab 10 mg | Allersoothe | 2238098 | Sep 2022 to 2025 |
| PSS | Promethazine hydrochloride | Tab 25 mg | Allersoothe | 2238128 | Sep 2022 to 2025 |
| PSS | Propofol | Inj 10 mg per ml, 20 ml ampoule | Fresofol 1% MCT/LCT | 2444003 | Jan 2023 to 2025 |
| PSS | Propofol | Inj 10 mg per ml, 100 ml vial | Fresofol 1% MCT/LCT | 2444038 | Jan 2023 to 2025 |
| PSS | Propofol | Inj 10 mg per ml, 50 ml vial | Fresofol 1% MCT/LCT | 2444011 | Jan 2023 to 2025 |
| HSS | Propranolol | Tab 10 mg | Drofate | 2611414 | Mar 2022 to 2027 |
| HSS | Propranolol | Tab 40 mg | IPCA-Propranolol | 2618664 | Mar 2022 to 2027 |
| PSS | Pyridoxine hydrochloride | Tab 25 mg | Vitamin B6 25 | 2473534 | Feb 2024 to 2026 |
| PSS | Quetiapine | Tab 100 mg | Quetapel | 2252880 | Feb 2024 to 2026 |
| PSS | Quetiapine | Tab 200 mg | Quetapel | 2252902 | Feb 2024 to 2026 |
| PSS | Quetiapine | Tab 25 mg | Quetapel | 2476266 | Feb 2024 to 2026 |
| PSS | Quetiapine | Tab 300 mg | Quetapel | 2476274 | Feb 2024 to 2026 |
| PSS | Quinapril | Tab 10 mg | Arrow-Quinapril 10 | 2427885 | Feb 2022 to 2024 |
| PSS | Quinapril | Tab 20 mg | Arrow-Quinapril 20 | 2427893 | Feb 2022 to 2024 |
| PSS | Quinapril | Tab 5 mg | Arrow-Quinapril 5 | 2427877 | Feb 2022 to 2024 |
| PSS | Quinapril with hydrochlorothiazide | Tab 10 mg with hydrochlorothiazide 12.5 mg | Accuretic 10 | 2022923 | Mar 2022 to 2024 |
| PSS | Quinapril with hydrochlorothiazide | Tab 20 mg with hydrochlorothiazide 12.5 mg | Accuretic 20 | 2022931 | Mar 2022 to 2024 |
| PSS | Ramipril | Cap 1.25 mg | Tryzan | 2635747 | May 2023 to 2024 |
| PSS | Ramipril | Cap 10 mg | Tryzan | 2635771 | May 2023 to 2024 |
| PSS | Ramipril | Cap 2.5 mg | Tryzan | 2635755 | May 2023 to 2024 |
| PSS | Ramipril | Cap 5 mg | Tryzan | 2635763 | May 2023 to 2024 |
| HSS | Rasagiline | Tab 1mg | Azilect | 2611449 | Jan 2022 to 2024 |
| PSS | Remifentanil | Inj 1 mg vial | Remifentanil-AFT | 2390388 | Feb 2024 to 2026 |
| PSS | Remifentanil | Inj 2 mg vial | Remifentanil-AFT | 2390396 | Feb 2024 to 2026 |
| PSS | Rifampicin | Cap 150 mg | Rifadin | 251186 | Dec 2023 to 2026 |
| PSS | Rifampicin | Cap 300 mg | Rifadin | 251194 | Dec 2023 to 2026 |
| PSS | Rifampicin | Inj 600 mg vial | Rifadin | 698121 | Dec 2023 to 2026 |
| PSS | Rifampicin | Oral liq 100 mg per 5 ml | Rifadin | 251208 | Dec 2023 to 2026 |
| PSS | Riluzole | Tab 50 mg | Rilutek | 238732 | Dec 2021 to 2024 |
| PSS | Risedronate sodium | Tab 35 mg | Risedronate Sandoz | 2440202 | Jun 2023 to 2025 |
| PSS | Risperidone | Oral liq 1 mg per ml | Risperon | 2325640 | Mar 2024 to 2026 |
| PSS | Risperidone | Tab 0.5 mg | Risperidone (Teva) | 2466899 | Mar 2024 to 2026 |
| PSS | Risperidone | Tab 1 mg | Risperidone (Teva) | 2466902 | Mar 2024 to 2026 |
| PSS | Risperidone | Tab 2 mg | Risperidone (Teva) | 2466910 | Mar 2024 to 2026 |
| PSS | Risperidone | Tab 3 mg | Risperidone (Teva) | 2466929 | Mar 2024 to 2026 |
| PSS | Risperidone | Tab 4 mg | Risperidone (Teva) | 2466937 | Mar 2024 to 2026 |
| PSS | Rivaroxaban | Tab 10 mg | Xarelto | 2545152 | Dec 2023 to 2026 |
| PSS | Rivaroxaban | Tab 15 mg | Xarelto | 2425920 | Dec 2023 to 2026 |
| PSS | Rivaroxaban | Tab 20 mg | Xarelto | 2425947 | Dec 2023 to 2026 |
| PSS | Rivastigmine | Patch 4.6 mg per 24 hour | Rivastigmine Patch BNM 5 | 2611570 | Feb 2022 to 2024 |
| PSS | Rivastigmine | Patch 9.5 mg per 24 hour | Rivastigmine Patch BNM 10 | 2611589 | Feb 2022 to 2024 |
| PSS | Rizatriptan | Tab orodispersible 10 mg | Rizamelt | 2394634 | Feb 2024 to 2026 |
| PSS | Rocuronium bromide | Inj 10 mg per ml, 5 ml ampoule | Hameln | 2577143 | Jan 2023 to 2025 |
| PSS | Ropinirole hydrochloride | Tab 0.25 mg | Ropin | 2310856 | Jan 2023 to 2025 |
| PSS | Ropinirole hydrochloride | Tab 1 mg | Ropin | 2310864 | Jan 2023 to 2025 |
| PSS | Ropinirole hydrochloride | Tab 2 mg | Ropin | 2310872 | Jan 2023 to 2025 |
| PSS | Ropinirole hydrochloride | Tab 5 mg | Ropin | 2310880 | Jan 2023 to 2025 |
| PSS | Ropivacaine hydrochloride | Inj 10 mg per ml, 10 ml ampoule | Ropivacaine Kabi | 2478749 | Feb 2024 to 2026 |
| PSS | Ropivacaine hydrochloride | Inj 10 mg per ml, 20 ml ampoule | Ropivacaine Kabi | 2478765 | Feb 2024 to 2026 |
| PSS | Ropivacaine hydrochloride | Inj 2 mg per ml, 10 ml ampoule | Ropivacaine Kabi | 2478757 | Feb 2024 to 2026 |
| PSS | Ropivacaine hydrochloride | Inj 2 mg per ml, 20 ml ampoule | Ropivacaine Kabi | 2478714 | Feb 2024 to 2026 |
| PSS | Ropivacaine hydrochloride | Inj 2 mg per ml, 100 ml bag | Ropivacaine Kabi | 2479125 | Feb 2024 to 2026 |
| PSS | Ropivacaine hydrochloride | Inj 2 mg per ml, 200 ml bag | Ropivacaine Kabi | 2479117 | Feb 2024 to 2026 |
| PSS | Ropivacaine hydrochloride | Inj 7.5 mg per ml, 10 ml ampoule | Ropivacaine Kabi | 2478722 | Feb 2024 to 2026 |
| PSS | Ropivacaine hydrochloride | Inj 7.5 mg per ml, 20 ml ampoule | Ropivacaine Kabi | 2478730 | Feb 2024 to 2026 |
| PSS | Rosuvastatin | Tab 10 mg | Rosuvastatin Viatris | 2616750 | Oct 2024 to 2026 |
| PSS | Rosuvastatin | Tab 10 mg | Rosuvastatin Viatris | 2651149 | Oct 2024 to 2026 |
| PSS | Rosuvastatin | Tab 20 mg | Rosuvastatin Viatris | 2651157 | Apr 2024 to 2026 |
| PSS | Rosuvastatin | Tab 40 mg | Rosuvastatin Viatris | 2651165 | Apr 2024 to 2026 |
| PSS | Rosuvastatin | Tab 5 mg | Rosuvastatin Viatris | 2616742 | Oct 2024 to 2026 |
| PSS | Rosuvastatin | Tab 5 mg | Rosuvastatin Viatris | 2651130 | Oct 2024 to 2026 |
| HSS | Rotavirus oral vaccine | Oral susp live attenuated human rotavirus 1,000,000 CCID50 per dose, prefilled oral applicator | Rotarix | 2509415 | Oct 2020 to 2024 |
| PSS | Roxithromycin | Tab 150 mg | Arrow-Roxithromycin | 2246236 | Aug 2023 to 2026 |
| PSS | Roxithromycin | Tab 300 mg | Arrow-Roxithromycin | 2246228 | Aug 2023 to 2026 |
| PSS | Salbutamol | Oral liq 400 mcg per ml | Ventolin | 2140543 | Mar 2022 to 2024 |
| PSS | Salbutamol | Nebuliser soln 1 mg per ml, 2.5 ml ampoule | Asthalin | 2154315 | Jan 2022 to 2024 |
| PSS | Salbutamol | Nebuliser soln 2 mg per ml, 2.5 ml ampoule | Asthalin | 2154323 | Jan 2022 to 2024 |
| PSS | Salbutamol with ipratropium bromide | Nebuliser soln 2.5 mg with ipratropium bromide 0.5 mg per 2.5 ml ampoule | Duolin | 2039281 | Jan 2022 to 2024 |
| PSS | Sertraline | Tab 100 mg | Setrona | 2570858 | Apr 2023 to 2025 |
| PSS | Sertraline | Tab 50 mg | Setrona | 2570831 | Apr 2023 to 2025 |
| PSS | Sildenafil | Tab 100 mg | Vedafil | 2377810 | Jan 2022 to 2024 |
| PSS | Sildenafil | Tab 25 mg | Vedafil | 2377764 | Jan 2022 to 2024 |
| PSS | Sildenafil | Tab 50 mg | Vedafil | 2377780 | Jan 2022 to 2024 |
| PSS | Simvastatin | Tab 10 mg | Simvastatin Mylan | 2520087 | Mar 2024 to 2026 |
| PSS | Simvastatin | Tab 20 mg | Simvastatin Viatris | 2643561 | Mar 2024 to 2026 |
| PSS | Simvastatin | Tab 40 mg | Simvastatin Mylan | 2520109 | Mar 2024 to 31~May~2024 |
| PSS | Simvastatin | Tab 80 mg | Simvastatin Mylan | 2520117 | Mar 2024 to 31~May~2024 |
| PSS | Sodium chloride | Inj 0.9%, 5 ml ampoule | Fresenius Kabi | 2565749 | Jan 2023 to 2025 |
| PSS | Sodium chloride | Inj 0.9%, 10 ml ampoule | Fresenius Kabi | 2565757 | Jan 2023 to 2025 |
| PSS | Sodium chloride | Inj 0.9%, 3 ml syringe, non-sterile pack | BD PosiFlush | 2476371 | Mar 2023 to 2025 |
| PSS | Sodium chloride | Inj 0.9%, 5 ml syringe, non-sterile pack | BD PosiFlush | 2476398 | Mar 2023 to 2025 |
| PSS | Sodium chloride | Inj 0.9%, 10 ml syringe, non-sterile pack | BD PosiFlush | 2476401 | Mar 2023 to 2025 |
| PSS | Sodium chloride | Inj 0.9%, 20 ml ampoule | Fresenius Kabi | 2565730 | Jan 2023 to 2025 |
| PSS | Sodium citrate | Oral liq 8.8% (300 mmol/l) | Biomed | 345865 | Jan 2022 to 2024 |
| PSS | Sodium citrate with sodium lauryl sulphoacetate | Enema 90 mg with sodium lauryl sulphoacetate 9 mg per ml, 5 ml | Micolette | 2262673 | Jun 2023 to 2025 |
| PSS | Sodium citro-tartrate | Grans eff 4 g sachets | Ural | 298638 | Feb 2024 to 2026 |
| PSS | Sodium cromoglicate | Eye drops 2% | Allerfix | 2645416 | Mar 2023 to 2025 |
| PSS | Sodium fusidate [Fusidic acid] | Crm 2% | Foban | 2556170 | Dec 2021 to 2024 |
| PSS | Sodium fusidate [Fusidic acid] | Oint 2% | Foban | 2556189 | Dec 2021 to 2024 |
| PSS | Sodium hyaluronate [Hyaluronic acid] | Inj 18 mg per ml, 0.85 ml syringe | Healon GV Pro | 2618540 | Dec 2022 to 2025 |
| PSS | Sodium hyaluronate [Hyaluronic acid] | Inj 23 mg per ml, 0.6 ml syringe | Healon 5 | 346721 | Dec 2022 to 2025 |
| PSS | Sodium hyaluronate [Hyaluronic acid] | Eye drops 1 mg per ml | Hylo-Fresh | 2608162 | Jan 2022 to 2024 |
| PSS | Sodium hyaluronate [Hyaluronic acid] | Inj 10 mg per ml, 0.85 ml syringe | Healon | 470619 | Dec 2022 to 2025 |
| PSS | Solifenacin succinate | Tab 10 mg | Solifenacin Viatris | 2645327 | Jun 2023 to 2024 |
| PSS | Solifenacin succinate | Tab 5 mg | Solifenacin Viatris | 2645319 | Jun 2023 to 2024 |
| PSS | Somatropin | Inj 10 mg cartridge | Omnitrope | 2461528 | Jan 2022 to 2024 |
| PSS | Somatropin | Inj 15 mg cartridge | Omnitrope | 2461501 | Jan 2022 to 2024 |
| PSS | Somatropin | Inj 5 mg cartridge | Omnitrope | 2461536 | Jan 2022 to 2024 |
| PSS | Sotalol | Tab 160 mg | Mylan | 2127911 | Jan 2023 to 2025 |
| PSS | Sotalol | Tab 80 mg | Mylan | 2127903 | Jan 2023 to 2025 |
| PSS | Spironolactone | Tab 100 mg | Spiractin | 2435187 | Sep 2022 to 2025 |
| PSS | Spironolactone | Tab 25 mg | Spiractin | 2435179 | Sep 2022 to 2025 |
| PSS | Sugammadex | Inj 100 mg per ml, 2 ml vial | Sugammadex BNM | 2632314 | Aug 2022 to 2024 |
| PSS | Sugammadex | Inj 100 mg per ml, 5 ml vial | Sugammadex BNM | 2632322 | Aug 2022 to 2024 |
| PSS | Sumatriptan | Inj 12 mg per ml, 0.5 ml prefilled pen | Clustran | 2647958 | Apr 2024 to 2025 |
| HSS | Sumatriptan | Tab 100 mg | Sumagran | 2605856 | Feb 2022 to 2027 |
| HSS | Sumatriptan | Tab 50 mg | Sumagran | 2605848 | Feb 2022 to 2027 |
| PSS | Sunitinib | Cap 12.5 mg | Sunitinib Pfizer | 2630303 | Jul 2022 to 2024 |
| PSS | Sunitinib | Cap 25 mg | Sunitinib Pfizer | 2630311 | Jul 2022 to 2024 |
| PSS | Sunitinib | Cap 50 mg | Sunitinib Pfizer | 2630338 | Jul 2022 to 2024 |
| PSS | Sunscreen, proprietary | Lotn | Marine Blue Lotion SPF 50+ | 2454203 | Apr 2023 to 2025 |
| PSS | Suxamethonium chloride | Inj 50 mg per ml, 2 ml ampoule | Martindale | 2442205 | Feb 2024 to 2026 |
| PSS | Tacrolimus | Oint 0.1% | Zematop | 2607646 | Dec 2023 to 2026 |
| PSS | Tamoxifen citrate | Tab 10 mg | Tamoxifen Sandoz | 2556944 | Dec 2023 to 2026 |
| PSS | Tamoxifen citrate | Tab 20 mg | Tamoxifen Sandoz | 2556952 | Dec 2023 to 2026 |
| PSS | Tamsulosin hydrochloride | Cap 400 mcg | Tamsulosin-Rex | 2438526 | Jan 2023 to 2025 |
| PSS | Teicoplanin | Inj 400 mg vial | Targocid | 280631 | Jun 2022 to 2024 |
| PSS | Temazepam | Tab 10 mg | Normison | 2184877 | Feb 2024 to 2026 |
| PSS | Tenofovir disoproxil | Tab 245 mg (300 mg as a maleate) | Tenofovir Disoproxil Viatris | 2638061 | Sep 2023 to 2025 |
| PSS | Tenoxicam | Tab 20 mg | Tilcotil | 2520559 | Jan 2023 to 2025 |
| PSS | Terbinafine | Tab 250 mg | Deolate | 2597160 | Feb 2024 to 2026 |
| PSS | Teriparatide | Inj 250 mcg per ml, 2.4 ml | Teriparatide - Teva | 2670399 | Jun 2024 to 2025 |
| PSS | Testosterone | Gel (transdermal) 16.2 mg per g | Testogel | 2676605 | Jul 2024 to 2027 |
| PSS | Tetrabenazine | Tab 25 mg | Motetis | 2394383 | Apr 2023 to 2025 |
| PSS | Thiamine hydrochloride | Tab 50 mg | Thiamine multichem | 2646552 | Apr 2023 to 2025 |
| PSS | Thiotepa | Inj 100 mg vial | Tepadina | 2487977 | Apr 2024 to 2026 |
| PSS | Thiotepa | Inj 15 mg vial | Tepadina | 2487985 | Apr 2024 to 2026 |
| PSS | Ticagrelor | Tab 90 mg | Ticagrelor Sandoz | 2638770 | Mar 2023 to 2024 |
| PSS | Timolol | Eye drops 0.25% | Arrow-Timolol | 2390663 | Mar 2024 to 2026 |
| PSS | Timolol | Eye drops 0.5% | Arrow-Timolol | 2390655 | Mar 2024 to 2026 |
| PSS | Tobramycin | Solution for inhalation 60 mg per ml, 5 ml | Tobramycin BNM | 2601648 | Dec 2023 to 2026 |
| PSS | Tobramycin | Inj 40 mg per ml, 2 ml vial | Tobramycin (Viatris) | 2635690 | Jul 2023 to 2024 |
| PSS | Tramadol hydrochloride | Cap 50 mg | Arrow-Tramadol | 2351889 | Jan 2024 to 2026 |
| PSS | Tramadol hydrochloride | Inj 50 mg per ml, 2 ml ampoule | Tramal 100 | 471216 | May 2024 to 2026 |
| PSS | Tramadol hydrochloride | Inj 50 mg per ml, 2 ml ampoule | Tramal 100 | 2650932 | May 2024 to 2026 |
| PSS | Tramadol hydrochloride | Inj 50 mg per ml, 1 ml ampoule | Tramal 50 | 471208 | May 2024 to 2026 |
| PSS | Tramadol hydrochloride | Inj 50 mg per ml, 1 ml ampoule | Tramal 50 | 2650940 | May 2024 to 2026 |
| PSS | Tramadol hydrochloride | Tab sustained-release 100 mg | Tramal SR 100 | 2149508 | May 2024 to 2026 |
| PSS | Tramadol hydrochloride | Tab sustained-release 100 mg | Tramal SR 100 | 2650959 | May 2024 to 2026 |
| PSS | Tramadol hydrochloride | Tab sustained-release 150 mg | Tramal SR 150 | 2149532 | May 2024 to 2026 |
| PSS | Tramadol hydrochloride | Tab sustained-release 150 mg | Tramal SR 150 | 2650967 | May 2024 to 2026 |
| PSS | Tramadol hydrochloride | Tab sustained-release 200 mg | Tramal SR 200 | 2149524 | May 2024 to 2026 |
| PSS | Tramadol hydrochloride | Tab sustained-release 200 mg | Tramal SR 200 | 2650975 | May 2024 to 2026 |
| PSS | Tranexamic acid | Inj 100 mg per ml, 10 ml ampoule | Tranexamic-AFT | 2497174 | Dec 2021 to 2024 |
| PSS | Tranexamic acid | Inj 100 mg per ml, 5 ml ampoule | Tranexamic-AFT | 2497166 | Dec 2021 to 2024 |
| PSS | Tranexamic acid | Tab 500 mg | Mercury Pharma | 2574020 | Jun 2023 to 2025 |
| PSS | Trastuzumab (Herzuma) | Inj 150 mg vial | Herzuma | 2670127 | Jun 2024 to 31~May~2027 |
| PSS | Trastuzumab (Herzuma) | Inj 440 mg vial | Herzuma | 2670135 | Jun 2024 to 31~May~2027 |
| PSS | Travoprost | Eye drops 0.004% | Travatan | 2550091 | Dec 2021 to 2024 |
| PSS | Tretinoin | Crm 0.05% | ReTrieve | 2358751 | Jan 2022 to 2024 |
| PSS | Triamcinolone acetonide | Paste 0.1% | Kenalog in Orabase | 253790 | Feb 2024 to 2026 |
| PSS | Triamcinolone acetonide | Crm 0.02% | Aristocort | 250066 | Feb 2024 to 2026 |
| PSS | Triamcinolone acetonide | Oint 0.02% | Aristocort | 250082 | Feb 2024 to 2026 |
| PSS | Triamcinolone acetonide | Inj 10 mg per ml, 1 ml ampoule | Kenacort-A 10 | 282499 | Feb 2024 to 2026 |
| PSS | Triamcinolone acetonide | Inj 40 mg per ml, 1 ml ampoule | Kenacort-A 40 | 253766 | Feb 2024 to 2026 |
| PSS | Trientine | Cap 250 mg | Trientine Waymade | 2621738 | Oct 2024 to 2025 |
| PSS | Trimethoprim | Tab 300 mg | TMP | 648507 | Jan 2022 to 2024 |
| PSS | Trimethoprim with sulphamethoxazole [Co-trimoxazole] | Tab 80 mg with sulphamethoxazole 400 mg | Trisul | 283363 | Jan 2022 to 2024 |
| HSS | Tuberculin PPD [Mantoux] test | Inj 5 TU per 0.1 ml, 1 ml vial | Tubersol | 703338 | Oct 2020 to 2024 |
| PSS | Ursodeoxycholic acid | Cap 250 mg | Ursosan | 2397528 | Feb 2024 to 2026 |
| PSS | Valaciclovir | Tab 1,000 mg | Vaclovir | 2483912 | Jan 2022 to 2024 |
| PSS | Valaciclovir | Tab 500 mg | Vaclovir | 2483904 | Jan 2022 to 2024 |
| PSS | Valganciclovir | Tab 450 mg | Valganciclovir Viatris | 2635682 | Sep 2023 to 2024 |
| PSS | Vancomycin | Inj 500 mg vial | Mylan | 2195267 | Feb 2024 to 2026 |
| PSS | Varenicline | Tab 0.5 mg x 11 and 1 mg x 42 | Varenicline Pfizer | 2553155 | Jan 2022 to 2024 |
| PSS | Varenicline | Tab 1 mg | Varenicline Pfizer | 2553163 | Jan 2022 to 2024 |
| HSS | Varicella vaccine [Chickenpox vaccine] | Inj 1350 PFU prefiiled syringe | Varivax | 2173085 | Oct 2020 to 2024 |
| HSS | Varicella vaccine [Chickenpox vaccine] | Inj 1350 PFU prefiiled syringe | Varivax | 2593793 | Oct 2020 to 2024 |
| PSS | Vinorelbine | Cap 20 mg | Vinorelbine Te Arai | 2651912 | Oct 2023 to 2025 |
| PSS | Vinorelbine | Cap 30 mg | Vinorelbine Te Arai | 2547880 | Oct 2023 to 2025 |
| PSS | Vinorelbine | Cap 80 mg | Vinorelbine Te Arai | 2651920 | Oct 2023 to 2025 |
| PSS | Voriconazole | Inj 200 mg vial | AFT | 2645122 | Aug 2023 to 2025 |
| PSS | Water | Inj 10 ml ampoule | Multichem | 2208326 | Sep 2023 to 2025 |
| PSS | Water | Inj 20 ml ampoule | Fresenius Kabi | 2565692 | Jan 2023 to 2025 |
| PSS | Zinc and castor oil | Oint | Evara | 2658399 | Nov 2023 to 2025 |
| PSS | Zoledronic acid | Inj 4 mg per 5 ml, vial | Zoledronic acid Viatris | 2631830 | Jun 2023 to 2024 |
| PSS | Zoledronic acid | Inj 5 mg per 100 ml, bag | Zoledronic Acid Viatris | 2636743 | Jun 2023 to 2025 |